Biogen Inc. (BIIB) NASDAQ
$239.29 0.17 (0.07%)
Market Cap: $34.67B
As of 12/08/23 04:00 PM EST. Market closed.

Biogen Inc. (BIIB)
NASDAQ
$239.29
0.17 (0.07%)
Market Cap: $34.67B
As of 12/08/23 04:00 PM EST. Market closed.
through cutting-edge science and medicine, biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. founded in 1978, biogen is a pioneer in biotechnology and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal ... read more
through cutting-edge science and medicine, biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. founded in 1978, biogen is a pioneer in biotechnology and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including alzheimer’s disease, parkinson’s disease and amyotrophic lateral sclerosis. biogen also manufactures and commercializes biosimilars of advanced biologics. with approximately 7000 people worldwide, we are truly a global organization, headquartered in cambridge, massachusetts, which is also home to our research operations. our international headquarters are based in zug, switzerland and we have world-class manufacturing facilities in north carolina and denmark. we offer therapies globally through direct affili read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sep 01, 2023 | Option Exercise | $267.17 | 2,704 | 722,428 | 12,728 | Sep 06, 2023, 06:08 PM |
Singhal Priya | Head of Development | Sep 01, 2023 | Option Exercise | $267.17 | 807 | 215,606 | 3,785 | Sep 06, 2023, 06:06 PM |
Singhal Priya | Head of Development | Sep 05, 2023 | Sale | $269.43 | 431 | 116,124 | 3,354 | Sep 06, 2023, 06:06 PM |
Izzar Rachid | Head of Global Product Strat. | Jun 30, 2023 | Option Exercise | $284.85 | 244 | 69,503 | 6,144 | Jul 05, 2023, 05:37 PM |
Kramer Robin | Chief Accounting Officer | Jun 30, 2023 | Option Exercise | $284.85 | 122 | 34,752 | 3,974 | Jul 05, 2023, 05:35 PM |
Singhal Priya | Head of Development | Jun 30, 2023 | Option Exercise | $284.85 | 153 | 43,582 | 3,005 | Jul 05, 2023, 05:33 PM |
Singhal Priya | Head of Development | Jul 03, 2023 | Sale | $282.87 | 81 | 22,912 | 2,924 | Jul 05, 2023, 05:33 PM |
Gregory Ginger | EVP, Human Resources | Apr 28, 2023 | Sale | $300.00 | 2,681 | 804,300 | 8,483 | May 02, 2023, 08:05 PM |
Singhal Priya | Head of Development | Apr 04, 2023 | Sale | $277.11 | 91 | 25,217 | 2,843 | Apr 06, 2023, 06:37 PM |
Murphy Nicole | Head of Pharm Ops and Tech | Mar 31, 2023 | Option Exercise | $278.03 | 116 | 32,251 | 5,702 | Apr 04, 2023, 05:21 PM |
Singhal Priya | Head of Development | Mar 28, 2023 | Sale | $270.06 | 568 | 153,394 | 2,842 | Mar 30, 2023, 06:31 PM |
Singhal Priya | Head of Development | Mar 02, 2023 | Option Exercise | $268.75 | 687 | 184,631 | 3,410 | Mar 06, 2023, 06:13 PM |
Singhal Priya | Head of Development | Feb 17, 2023 | Option Exercise | $278.38 | 151 | 42,035 | 3,800 | Feb 22, 2023, 05:07 PM |
Murphy Nicole | Head of Pharm Ops and Tech | Feb 17, 2023 | Option Exercise | $278.38 | 233 | 64,863 | 5,099 | Feb 22, 2023, 05:06 PM |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Feb 17, 2023 | Option Exercise | $278.38 | 1,310 | 364,678 | 7,586 | Feb 22, 2023, 05:03 PM |
Kramer Robin | Chief Accounting Officer | Feb 17, 2023 | Option Exercise | $278.38 | 238 | 66,254 | 3,332 | Feb 22, 2023, 05:01 PM |
Izzar Rachid | Head of Global Product Strat. | Feb 17, 2023 | Option Exercise | $278.38 | 371 | 103,279 | 5,117 | Feb 22, 2023, 04:57 PM |
Gregory Ginger | EVP, Human Resources | Feb 17, 2023 | Option Exercise | $278.38 | 867 | 241,355 | 9,280 | Feb 22, 2023, 04:54 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Feb 17, 2023 | Option Exercise | $278.38 | 929 | 258,615 | 45,911 | Feb 22, 2023, 04:49 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Feb 10, 2023 | Option Exercise | $286.30 | 4,202 | 1,203,033 | 47,657 | Feb 14, 2023, 09:46 PM |
Gregory Ginger | EVP, Human Resources | Feb 10, 2023 | Option Exercise | $286.30 | 3,306 | 946,508 | 12,257 | Feb 14, 2023, 09:44 PM |
Izzar Rachid | Head of Global Product Strat. | Feb 10, 2023 | Option Exercise | $286.30 | 1,324 | 379,061 | 6,130 | Feb 14, 2023, 09:41 PM |
Kramer Robin | Chief Accounting Officer | Feb 10, 2023 | Option Exercise | $286.30 | 590 | 168,917 | 3,831 | Feb 14, 2023, 09:37 PM |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Feb 10, 2023 | Option Exercise | $286.30 | 1,105 | 316,361 | 8,896 | Feb 14, 2023, 09:25 PM |
Murphy Nicole | Head of Pharm Ops and Tech | Feb 10, 2023 | Option Exercise | $286.30 | 1,387 | 397,098 | 5,694 | Feb 14, 2023, 09:23 PM |
Singhal Priya | Head of Development | Feb 10, 2023 | Option Exercise | $286.30 | 372 | 106,504 | 3,491 | Feb 14, 2023, 09:21 PM |
Gregory Ginger | EVP, Human Resources | Nov 14, 2022 | Sale | $300.11 | 5,610 | 1,683,617 | 5,711 | Dec 12, 2022, 08:00 PM |
Kramer Robin | Chief Accounting Officer | Dec 08, 2022 | Option Exercise | $289.10 | 156 | 45,100 | 2,212 | Dec 12, 2022, 06:04 PM |
Izzar Rachid | Head of Alzheimer's Disease | Dec 02, 2022 | Option Exercise | $298.90 | 759 | 226,865 | 3,061 | Dec 06, 2022, 06:37 PM |
Murphy Nicole | Head of Pharm Ops and Tech | Dec 02, 2022 | Option Exercise | $298.90 | 39 | 11,657 | 2,768 | Dec 06, 2022, 06:33 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Oct 27, 2022 | Sale | $280.70 | 5,532 | 1,552,832 | 39,396 | Oct 28, 2022, 07:19 PM |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sep 01, 2022 | Option Exercise | $199.79 | 2,428 | 485,090 | 6,745 | Sep 06, 2022, 07:31 PM |
Murphy Nicole | Head of Pharm Ops and Tech | Aug 01, 2022 | Option Exercise | $209.26 | 319 | 66,754 | 2,676 | Aug 03, 2022, 05:40 PM |
Kramer Robin | Chief Accounting Officer | Jul 01, 2022 | Option Exercise | $210.63 | 74 | 15,587 | 2,018 | Jul 06, 2022, 07:33 PM |
Izzar Rachid | Head of Alzheimer's Disease | Jul 01, 2022 | Option Exercise | $210.63 | 148 | 31,173 | 2,110 | Jul 06, 2022, 07:28 PM |
Murphy Nicole | Head of Pharm Ops and Tech | Apr 01, 2022 | Option Exercise | $210.65 | 84 | 17,695 | 1,813 | Apr 05, 2022, 05:44 PM |
Vounatsos Michel | Chief Executive Officer | Feb 18, 2022 | Option Exercise | $209.79 | 2,746 | 576,083 | 67,261 | Feb 23, 2022, 04:21 PM |
Murphy Nicole | Head of Pharm Ops and Tech | Feb 18, 2022 | Option Exercise | $209.79 | 110 | 23,077 | 1,658 | Feb 23, 2022, 04:20 PM |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Feb 18, 2022 | Option Exercise | $209.79 | 977 | 204,965 | 4,427 | Feb 23, 2022, 04:19 PM |
Gregory Ginger | EVP, Human Resources | Feb 18, 2022 | Option Exercise | $209.79 | 616 | 129,231 | 11,219 | Feb 23, 2022, 04:15 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Feb 18, 2022 | Option Exercise | $209.79 | 659 | 138,252 | 44,928 | Feb 23, 2022, 04:14 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Feb 12, 2022 | Option Exercise | $214.59 | 2,056 | 441,197 | 45,146 | Feb 15, 2022, 04:17 PM |
Gregory Ginger | EVP, Human Resources | Feb 12, 2022 | Option Exercise | $214.59 | 1,252 | 268,667 | 11,032 | Feb 15, 2022, 04:16 PM |
Guindo Chirfi | Head of Glob Prod Strat & Com | Feb 12, 2022 | Option Exercise | $214.59 | 2,342 | 502,570 | 7,451 | Feb 15, 2022, 04:15 PM |
Kramer Robin | Chief Accounting Officer | Dec 03, 2021 | Option Exercise | $223.92 | 100 | 22,392 | 1,132 | Dec 07, 2021, 04:09 PM |
Kramer Robin | Chief Accounting Officer | Dec 03, 2021 | Option Exercise | $223.92 | 339 | 75,909 | 1,210 | Dec 07, 2021, 04:09 PM |
Izzar Rachid | Head of Alzheimer's Disease | Dec 02, 2021 | Option Exercise | $228.52 | 165 | 37,706 | 1,106 | Dec 06, 2021, 04:14 PM |
Izzar Rachid | Head of Alzheimer's Disease | Dec 02, 2021 | Option Exercise | $228.52 | 372 | 85,009 | 1,271 | Dec 06, 2021, 04:14 PM |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sep 01, 2021 | Option Exercise | $338.24 | 2,582 | 873,336 | 3,423 | Sep 03, 2021, 04:08 PM |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | Sep 01, 2021 | Option Exercise | $338.24 | 6,005 | 2,031,131 | 4,864 | Sep 03, 2021, 04:08 PM |
Kramer Robin | Chief Accounting Officer | Jul 01, 2021 | Option Exercise | $348.92 | 74 | 25,820 | 871 | Jul 02, 2021, 04:34 PM |
Kramer Robin | Chief Accounting Officer | Jul 01, 2021 | Option Exercise | $348.92 | 251 | 87,579 | 945 | Jul 02, 2021, 04:34 PM |
Sandrock Alfred | Head of Research & Development | Jun 07, 2021 | Sale | $440.00 | 7,672 | 3,375,680 | 10,169 | Jun 09, 2021, 07:05 PM |
Guindo Chirfi | Head of Glob Prod Strat & Com | Jun 07, 2021 | Sale | $440.00 | 3,087 | 1,358,280 | 2,919 | Jun 09, 2021, 07:04 PM |
Posner Brian S | Director | Jun 04, 2021 | Sale | $274.17 | 360 | 98,701 | 7,400 | Jun 07, 2021, 07:02 PM |
Vounatsos Michel | Chief Executive Officer | Feb 12, 2021 | Option Exercise | $278.03 | 14,473 | 4,023,928 | 57,669 | Feb 17, 2021, 05:03 PM |
Sandrock Alfred | EVP, Research & Development | Feb 12, 2021 | Option Exercise | $278.03 | 3,510 | 975,885 | 19,138 | Feb 17, 2021, 05:01 PM |
Kramer Robin | SVP, Chief Accounting Officer | Feb 12, 2021 | Option Exercise | $278.03 | 115 | 31,973 | 664 | Feb 17, 2021, 04:59 PM |
Gregory Ginger | EVP, Human Resources | Feb 12, 2021 | Option Exercise | $278.03 | 2,182 | 606,661 | 8,892 | Feb 17, 2021, 04:56 PM |
Galdes Alphonse | EVP Pharmaceutical Oper & Tech | Feb 12, 2021 | Option Exercise | $278.03 | 715 | 198,791 | 4,681 | Feb 17, 2021, 04:54 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Feb 12, 2021 | Option Exercise | $278.03 | 3,896 | 1,083,205 | 42,805 | Feb 17, 2021, 04:52 PM |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | Feb 12, 2021 | Option Exercise | $278.03 | 940 | 261,348 | 6,483 | Feb 17, 2021, 12:00 AM |
Mantas Jesus B | Director | Feb 09, 2021 | Buy | $267.00 | 898 | 239,766 | 2,943 | Feb 10, 2021, 04:31 PM |
Kramer Robin | VP, Chief Accounting Officer | Dec 03, 2020 | Option Exercise | $244.09 | 22 | 5,370 | 373 | Dec 07, 2020, 09:08 PM |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | Dec 01, 2020 | Option Exercise | $243.16 | 562 | 136,656 | 3,790 | Dec 03, 2020, 05:41 PM |
Vounatsos Michel | Chief Executive Officer | Nov 30, 2020 | Buy | $241.30 | 3,100 | 748,045 | 34,810 | Dec 01, 2020, 04:57 PM |
Sandrock Alfred | EVP, Research & Development | Nov 04, 2020 | Sale | $350.00 | 1,500 | 525,000 | 13,066 | Nov 06, 2020, 09:39 PM |
Gregory Ginger | EVP, Human Resources | Jul 31, 2020 | Option Exercise | $274.69 | 223 | 61,256 | 4,691 | Aug 04, 2020, 04:12 PM |
SHERWIN STEPHEN A | Director | Mar 11, 2020 | Option Exercise | $58.46 | 12,278 | 717,772 | 16,517 | Mar 12, 2020, 06:56 PM |
SHERWIN STEPHEN A | Director | Mar 11, 2020 | Sale | $295.22 | 2,434 | 718,574 | 15,438 | Mar 12, 2020, 06:56 PM |
Vounatsos Michel | Chief Executive Officer | Feb 15, 2020 | Option Exercise | $333.00 | 2,150 | 715,950 | 31,625 | Feb 19, 2020, 06:20 PM |
Sandrock Alfred | EVP, Research & Development | Feb 15, 2020 | Option Exercise | $333.00 | 538 | 179,154 | 14,481 | Feb 19, 2020, 06:17 PM |
Galdes Alphonse | EVP Pharmaceutical Oper & Tech | Feb 15, 2020 | Option Exercise | $333.00 | 130 | 43,290 | 2,542 | Feb 19, 2020, 06:13 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Feb 15, 2020 | Option Exercise | $333.00 | 689 | 229,437 | 36,572 | Feb 19, 2020, 06:09 PM |
Kramer Robin | VP, Chief Accounting Officer | Feb 12, 2020 | Option Exercise | $331.76 | 46 | 15,261 | 236 | Feb 14, 2020, 06:37 PM |
Karp Daniel | EVP, Corporate Development | Feb 12, 2020 | Option Exercise | $331.76 | 294 | 97,537 | 930 | Feb 14, 2020, 06:36 PM |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | Feb 12, 2020 | Option Exercise | $331.76 | 504 | 167,207 | 3,871 | Feb 14, 2020, 06:34 PM |
Gregory Ginger | EVP, Human Resources | Feb 12, 2020 | Option Exercise | $331.76 | 1,159 | 384,510 | 4,603 | Feb 14, 2020, 06:32 PM |
Galdes Alphonse | EVP Pharmaceutical Oper & Tech | Feb 12, 2020 | Option Exercise | $331.76 | 351 | 116,448 | 2,231 | Feb 14, 2020, 06:30 PM |
CAPELLO JEFFREY D | EVP & Chief Financial Officer | Feb 12, 2020 | Option Exercise | $331.76 | 614 | 203,701 | 3,118 | Feb 14, 2020, 06:27 PM |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | Feb 12, 2020 | Option Exercise | $331.76 | 2,235 | 741,484 | 35,708 | Feb 14, 2020, 06:25 PM |
Vounatsos Michel | Chief Executive Officer | Feb 12, 2020 | Option Exercise | $331.76 | 4,895 | 1,623,965 | 28,928 | Feb 14, 2020, 06:19 PM |
Sandrock Alfred | EVP, Research & Development | Feb 12, 2020 | Option Exercise | $331.76 | 1,901 | 630,676 | 13,806 | Feb 14, 2020, 06:16 PM |
CAPELLO JEFFREY D | EVP & Chief Financial Officer | Jan 02, 2020 | Option Exercise | $294.20 | 406 | 119,445 | 1,813 | Jan 06, 2020, 12:00 AM |
Kramer Robin | VP, Chief Accounting Officer | Dec 03, 2019 | Option Exercise | $290.70 | 25 | 7,268 | 150 | Dec 05, 2019, 04:24 PM |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | Dec 01, 2019 | Option Exercise | $299.81 | 391 | 117,226 | 2,695 | Dec 03, 2019, 05:59 PM |
Posner Brian S | Director | Dec 02, 2019 | Sale | $292.35 | 1,055 | 308,429 | 6,995 | Dec 03, 2019, 05:58 PM |
Gregory Ginger | EVP, Human Resources | Aug 01, 2019 | Option Exercise | $243.06 | 208 | 50,556 | 2,215 | Aug 05, 2019, 04:20 PM |
Karp Daniel | EVP, Corporate Development | Jul 02, 2019 | Option Exercise | $236.37 | 58 | 13,709 | 264 | Jul 05, 2019, 04:51 PM |
Ehlers Michael D | EVP, Research and Development | Jun 01, 2019 | Option Exercise | $219.29 | 960 | 210,518 | 8,025 | Jun 04, 2019, 04:56 PM |
Vounatsos Michel | Chief Executive Officer | May 02, 2019 | Option Exercise | $230.52 | 658 | 151,682 | 21,829 | May 06, 2019, 04:20 PM |
DENNER ALEXANDER J | Director | May 02, 2019 | Buy | $231.24 | 38,000 | 8,787,120 | 643,000 | May 02, 2019, 05:06 PM |
DENNER ALEXANDER J | Director | May 01, 2019 | Buy | $229.46 | 30,000 | 6,883,800 | 605,000 | May 02, 2019, 05:06 PM |
DENNER ALEXANDER J | Director | Apr 30, 2019 | Buy | $229.25 | 50,342 | 11,540,904 | 575,000 | May 02, 2019, 05:06 PM |
Vounatsos Michel | Chief Executive Officer | May 01, 2019 | Buy | $231.48 | 4,351 | 1,007,169 | 21,007 | May 02, 2019, 04:30 PM |
PANGIA ROBERT W | Director | Mar 18, 2019 | Option Exercise | $52.22 | 6,114 | 319,273 | 24,701 | Mar 19, 2019, 04:08 PM |
PANGIA ROBERT W | Director | Mar 18, 2019 | Sale | $328.55 | 6,114 | 2,008,755 | 18,587 | Mar 19, 2019, 04:08 PM |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | Mar 01, 2019 | Option Exercise | $334.10 | 658 | 219,838 | 7,235 | Mar 05, 2019, 12:00 AM |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | Feb 22, 2019 | Option Exercise | $325.33 | 4,109 | 1,336,781 | 32,715 | Feb 26, 2019, 05:09 PM |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | Feb 22, 2019 | Option Exercise | $48.52 | 6,395 | 310,285 | 36,085 | Feb 26, 2019, 05:09 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 22, 2019 | Option Exercise | $325.33 | 739 | 240,419 | 10,409 | Feb 26, 2019, 05:07 PM |
Vounatsos Michel | Chief Executive Officer | Feb 15, 2019 | Option Exercise | $332.87 | 2,340 | 778,916 | 16,574 | Feb 20, 2019, 06:10 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 15, 2019 | Option Exercise | $332.87 | 586 | 195,062 | 9,485 | Feb 20, 2019, 06:08 PM |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | Feb 15, 2019 | Option Exercise | $332.87 | 643 | 214,035 | 7,325 | Feb 20, 2019, 06:07 PM |
Ehlers Michael D | EVP, Research and Development | Feb 15, 2019 | Option Exercise | $332.87 | 749 | 249,320 | 7,777 | Feb 20, 2019, 05:54 PM |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | Feb 15, 2019 | Option Exercise | $332.87 | 749 | 249,320 | 28,027 | Feb 20, 2019, 05:53 PM |
Vounatsos Michel | Chief Executive Officer | Feb 12, 2019 | Option Exercise | $319.43 | 2,622 | 837,545 | 13,645 | Feb 14, 2019, 06:33 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 12, 2019 | Option Exercise | $319.43 | 2,518 | 804,325 | 8,753 | Feb 14, 2019, 06:29 PM |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | Feb 12, 2019 | Option Exercise | $319.43 | 919 | 293,556 | 6,520 | Feb 14, 2019, 06:17 PM |
Gregory Ginger | EVP, Human Resources | Feb 12, 2019 | Option Exercise | $319.43 | 551 | 176,006 | 2,244 | Feb 14, 2019, 06:10 PM |
Ehlers Michael D | EVP, Research and Development | Feb 12, 2019 | Option Exercise | $319.43 | 1,267 | 404,718 | 6,841 | Feb 14, 2019, 06:07 PM |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | Feb 12, 2019 | Option Exercise | $319.43 | 1,021 | 326,138 | 27,091 | Feb 14, 2019, 06:04 PM |
DENNER ALEXANDER J | Director | Jan 30, 2019 | Buy | $324.86 | 30,000 | 9,745,860 | 491,858 | Feb 01, 2019, 04:19 PM |
DENNER ALEXANDER J | Director | Feb 01, 2019 | Buy | $328.45 | 7,000 | 2,299,164 | 524,658 | Feb 01, 2019, 04:19 PM |
DENNER ALEXANDER J | Director | Jan 31, 2019 | Buy | $330.52 | 25,800 | 8,527,391 | 517,658 | Feb 01, 2019, 04:19 PM |
CAPELLO JEFFREY D | EVP & Chief Financial Officer | Jan 02, 2019 | Option Exercise | $304.69 | 414 | 126,142 | 917 | Jan 04, 2019, 04:17 PM |
Guindo Chirfi | EVP Glob. Mkt Acc & Cust Innov | Dec 01, 2018 | Option Exercise | $333.72 | 409 | 136,491 | 2,543 | Dec 04, 2018, 08:21 PM |
Ehlers Michael D | EVP, Research and Development | Sep 26, 2018 | Sale | $350.00 | 1,000 | 350,000 | 4,281 | Sep 27, 2018, 04:16 PM |
Gregory Ginger | EVP, Human Resources | Aug 01, 2018 | Option Exercise | $344.06 | 163 | 56,082 | 1,044 | Aug 03, 2018, 04:14 PM |
Ehlers Michael D | EVP, Research and Development | Jun 01, 2018 | Option Exercise | $297.09 | 1,076 | 319,669 | 5,281 | Jun 05, 2018, 04:31 PM |
Vounatsos Michel | Chief Executive Officer | May 02, 2018 | Option Exercise | $274.13 | 750 | 205,598 | 9,368 | May 04, 2018, 06:09 PM |
DENNER ALEXANDER J | Director | Apr 25, 2018 | Buy | $269.91 | 48,000 | 12,955,680 | 461,858 | Apr 27, 2018, 07:48 AM |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | Mar 01, 2018 | Option Exercise | $282.35 | 642 | 181,269 | 4,302 | Mar 05, 2018, 04:41 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 27, 2018 | Sale | $290.83 | 259 | 75,325 | 6,553 | Feb 28, 2018, 05:39 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 23, 2018 | Option Exercise | $292.78 | 208 | 60,898 | 6,812 | Feb 27, 2018, 06:25 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 23, 2018 | Sale | $293.44 | 908 | 266,444 | 6,553 | Feb 27, 2018, 06:25 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 23, 2018 | Option Exercise | $292.78 | 28 | 8,198 | 4,744 | Feb 27, 2018, 06:24 PM |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | Feb 23, 2018 | Option Exercise | $292.78 | 381 | 111,549 | 24,844 | Feb 27, 2018, 06:22 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 22, 2018 | Option Exercise | $284.81 | 727 | 207,057 | 7,461 | Feb 26, 2018, 04:12 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 22, 2018 | Option Exercise | $284.81 | 58 | 16,519 | 4,680 | Feb 26, 2018, 12:00 AM |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | Feb 22, 2018 | Option Exercise | $284.81 | 727 | 207,057 | 24,368 | Feb 26, 2018, 12:00 AM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 20, 2018 | Sale | $292.00 | 743 | 216,956 | 6,553 | Feb 21, 2018, 04:10 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 15, 2018 | Sale | $298.85 | 1,294 | 386,712 | 7,296 | Feb 20, 2018, 08:09 PM |
Vounatsos Michel | Chief Executive Officer | Feb 15, 2018 | Option Exercise | $299.38 | 1,877 | 561,936 | 8,356 | Feb 20, 2018, 04:27 PM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 15, 2018 | Option Exercise | $299.38 | 596 | 178,430 | 8,590 | Feb 20, 2018, 04:25 PM |
Ehlers Michael D | EVP, Research and Development | Feb 15, 2018 | Option Exercise | $299.38 | 509 | 152,384 | 4,898 | Feb 20, 2018, 04:20 PM |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | Feb 15, 2018 | Option Exercise | $299.38 | 510 | 152,684 | 23,460 | Feb 20, 2018, 04:17 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 15, 2018 | Option Exercise | $299.38 | 56 | 16,765 | 4,544 | Feb 20, 2018, 12:00 AM |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | Feb 15, 2018 | Option Exercise | $299.38 | 442 | 132,326 | 4,412 | Feb 20, 2018, 12:00 AM |
Sandrock Alfred | EVP, Chief Medical Officer | Feb 12, 2018 | Option Exercise | $316.63 | 1,316 | 416,685 | 7,847 | Feb 14, 2018, 06:37 PM |
PANGIA ROBERT W | Director | Jan 09, 2018 | Option Exercise | $57.83 | 5,832 | 337,265 | 23,539 | Jan 10, 2018, 05:28 PM |
PANGIA ROBERT W | Director | Jan 09, 2018 | Sale | $329.65 | 5,832 | 1,922,519 | 17,707 | Jan 10, 2018, 05:28 PM |
Vounatsos Michel | Chief Executive Officer | Dec 29, 2017 | Buy | $320.55 | 780 | 250,029 | 4,879 | Jan 02, 2018, 04:21 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Dec 01, 2017 | Option Exercise | $319.35 | 157 | 50,138 | 4,542 | Dec 05, 2017, 04:36 PM |
DENNER ALEXANDER J | Director | Nov 29, 2017 | Buy | $319.84 | 10,000 | 3,198,400 | 413,858 | Nov 30, 2017, 07:30 AM |
DENNER ALEXANDER J | Director | Nov 28, 2017 | Buy | $316.12 | 20,000 | 6,322,400 | 403,858 | Nov 30, 2017, 07:30 AM |
DENNER ALEXANDER J | Director | Aug 31, 2017 | Option Exercise | $316.56 | 933 | 295,350 | 383,858 | Aug 31, 2017, 09:45 PM |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | Jul 25, 2017 | Sale | $290.01 | 4,974 | 1,442,510 | 22,258 | Jul 26, 2017, 04:22 PM |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | Jul 19, 2017 | Sale | $285.00 | 7,758 | 2,211,030 | 27,232 | Jul 20, 2017, 05:00 PM |
Posner Brian S | Director | Jun 09, 2017 | Sale | $256.31 | 1,084 | 277,840 | 6,330 | Jun 12, 2017, 04:29 PM |
Ehlers Michael D | EVP, Research and Development | Jun 01, 2017 | Option Exercise | $252.38 | 747 | 188,528 | 3,616 | Jun 05, 2017, 04:38 PM |
Vounatsos Michel | Chief Executive Officer | May 02, 2017 | Option Exercise | $271.34 | 564 | 153,036 | 4,099 | May 04, 2017, 04:16 PM |
Vounatsos Michel | Chief Executive Officer | May 01, 2017 | Buy | $271.35 | 1,402 | 380,433 | 2,927 | May 02, 2017, 04:18 PM |
DENNER ALEXANDER J | Director | Apr 27, 2017 | Buy | $278.50 | 73,858 | 20,569,476 | 383,858 | May 01, 2017, 05:47 PM |
Clancy Paul J | Executive VP and CFO | Apr 25, 2017 | Sale | $290.00 | 9,892 | 2,868,680 | 10,813 | Apr 27, 2017, 04:23 PM |
Clancy Paul J | Executive VP and CFO | Mar 13, 2017 | Sale | $291.55 | 9,891 | 2,883,721 | 20,705 | Mar 14, 2017, 07:32 PM |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | Mar 01, 2017 | Option Exercise | $293.26 | 157 | 46,042 | 561 | Mar 03, 2017, 06:07 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Mar 01, 2017 | Sale | $290.07 | 973 | 282,238 | 9,041 | Mar 03, 2017, 06:02 PM |
Clancy Paul J | Executive VP and CFO | Feb 28, 2017 | Option Exercise | $279.35 | 3,054 | 853,135 | 30,596 | Mar 02, 2017, 05:24 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Feb 28, 2017 | Option Exercise | $278.17 | 2,981 | 829,217 | 10,014 | Mar 02, 2017, 05:22 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 28, 2017 | Option Exercise | $278.54 | 2,409 | 670,996 | 34,990 | Mar 02, 2017, 05:20 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 28, 2017 | Option Exercise | $285.23 | 89 | 25,386 | 4,505 | Mar 02, 2017, 05:18 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Feb 28, 2017 | Option Exercise | $286.64 | 738 | 211,542 | 8,752 | Mar 02, 2017, 05:16 PM |
DiPietro Kenneth | EVP Human Resources | Feb 28, 2017 | Option Exercise | $278.66 | 2,456 | 684,399 | 7,177 | Mar 02, 2017, 05:12 PM |
PANGIA ROBERT W | Director | Jan 09, 2017 | Option Exercise | $52.22 | 5,450 | 284,599 | 22,078 | Jan 10, 2017, 04:15 PM |
PANGIA ROBERT W | Director | Jan 09, 2017 | Sale | $295.39 | 5,450 | 1,609,876 | 16,628 | Jan 10, 2017, 04:15 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Dec 01, 2016 | Option Exercise | $295.78 | 171 | 50,578 | 7,408 | Dec 05, 2016, 04:34 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Dec 01, 2016 | Sale | $296.53 | 48 | 14,233 | 7,360 | Dec 05, 2016, 04:34 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Dec 01, 2016 | Option Exercise | $295.78 | 53 | 15,676 | 3,884 | Dec 05, 2016, 04:32 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Oct 04, 2016 | Sale | $311.94 | 262 | 81,728 | 7,579 | Oct 05, 2016, 04:24 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Oct 01, 2016 | Option Exercise | $313.03 | 1,888 | 591,001 | 8,221 | Oct 04, 2016, 05:02 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Oct 03, 2016 | Sale | $313.00 | 380 | 118,940 | 7,841 | Oct 04, 2016, 05:02 PM |
DORSA CAROLINE | Director | Sep 22, 2016 | Option Exercise | $53.64 | 27,570 | 1,478,855 | 44,663 | Sep 26, 2016, 04:24 PM |
DORSA CAROLINE | Director | Sep 22, 2016 | Sale | $314.00 | 27,570 | 8,656,980 | 17,093 | Sep 26, 2016, 04:24 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 21, 2016 | Sale | $280.00 | 157 | 43,960 | 54,779 | Jul 22, 2016, 05:03 PM |
Koppel Adam | EVP, Strategy and Bus. Dev. | Jun 06, 2016 | Sale | $290.00 | 555 | 160,950 | 2,402 | Jun 07, 2016, 04:09 PM |
Koppel Adam | EVP, Strategy and Bus. Dev. | Jun 02, 2016 | Option Exercise | $289.73 | 534 | 154,716 | 2,957 | Jun 06, 2016, 08:48 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jun 03, 2016 | Sale | $290.00 | 842 | 244,180 | 54,936 | Jun 06, 2016, 08:14 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jun 01, 2016 | Sale | $287.97 | 487 | 140,241 | 55,778 | Jun 02, 2016, 04:39 PM |
SCANGOS GEORGE A | Chief Executive Officer | May 31, 2016 | Sale | $290.00 | 3,368 | 976,720 | 56,265 | Jun 02, 2016, 04:39 PM |
SCANGOS GEORGE A | Chief Executive Officer | May 25, 2016 | Sale | $280.00 | 157 | 43,960 | 59,633 | May 27, 2016, 08:59 AM |
SCANGOS GEORGE A | Chief Executive Officer | May 02, 2016 | Sale | $274.74 | 487 | 133,798 | 59,790 | May 04, 2016, 05:03 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | May 01, 2016 | Option Exercise | $274.99 | 113 | 31,074 | 3,007 | May 02, 2016, 04:36 PM |
Koppel Adam | EVP, Strategy and Bus. Dev. | Apr 06, 2016 | Sale | $275.00 | 102 | 28,050 | 1,848 | Apr 07, 2016, 05:03 PM |
SCANGOS GEORGE A | Chief Executive Officer | Apr 06, 2016 | Sale | $280.00 | 157 | 43,960 | 60,277 | Apr 07, 2016, 05:01 PM |
Artavanis-Tsakonas Spyridon | EVP, Chief Scientific Officer | Apr 02, 2016 | Option Exercise | $260.54 | 459 | 119,588 | 3,150 | Apr 05, 2016, 05:06 PM |
SCANGOS GEORGE A | Chief Executive Officer | Apr 01, 2016 | Sale | $258.83 | 487 | 126,050 | 60,434 | Apr 05, 2016, 05:02 PM |
SCANGOS GEORGE A | Chief Executive Officer | Mar 01, 2016 | Sale | $261.37 | 487 | 127,287 | 60,921 | Mar 03, 2016, 04:36 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Feb 25, 2016 | Sale | $261.90 | 183 | 47,928 | 7,990 | Feb 26, 2016, 04:08 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Feb 25, 2016 | Sale | $261.90 | 84 | 22,000 | 8,127 | Feb 26, 2016, 04:06 PM |
Clancy Paul J | Executive VP and CFO | Feb 23, 2016 | Option Exercise | $258.99 | 273 | 70,704 | 26,870 | Feb 25, 2016, 05:13 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 23, 2016 | Option Exercise | $258.99 | 22 | 5,698 | 2,687 | Feb 25, 2016, 05:09 PM |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 23, 2016 | Option Exercise | $258.99 | 48 | 12,432 | 2,549 | Feb 25, 2016, 05:07 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 23, 2016 | Option Exercise | $258.99 | 300 | 77,697 | 31,840 | Feb 25, 2016, 05:05 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2016 | Option Exercise | $258.99 | 382 | 98,934 | 30,516 | Feb 25, 2016, 05:04 PM |
Koppel Adam | EVP, Strategy and Bus. Dev. | Feb 23, 2016 | Option Exercise | $258.99 | 98 | 25,381 | 1,865 | Feb 25, 2016, 05:02 PM |
DiPietro Kenneth | EVP Human Resources | Feb 23, 2016 | Option Exercise | $258.99 | 300 | 77,697 | 3,937 | Feb 25, 2016, 05:01 PM |
Holtzman Steven H | EVP Corporate Development | Feb 23, 2016 | Option Exercise | $258.99 | 273 | 70,704 | 8,326 | Feb 25, 2016, 04:59 PM |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Feb 23, 2016 | Option Exercise | $258.99 | 162 | 41,956 | 8,211 | Feb 25, 2016, 04:57 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Feb 23, 2016 | Option Exercise | $258.99 | 164 | 42,474 | 8,173 | Feb 25, 2016, 04:52 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 23, 2016 | Option Exercise | $258.99 | 1,395 | 361,291 | 61,417 | Feb 25, 2016, 04:51 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 17, 2016 | Sale | $256.16 | 487 | 124,750 | 59,848 | Feb 19, 2016, 04:20 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Feb 17, 2016 | Sale | $256.16 | 722 | 184,948 | 7,990 | Feb 19, 2016, 04:18 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 12, 2016 | Option Exercise | $247.22 | 11,815 | 2,920,904 | 60,335 | Feb 17, 2016, 06:03 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2016 | Option Exercise | $247.22 | 1,552 | 383,685 | 30,088 | Feb 17, 2016, 06:01 PM |
DiPietro Kenneth | EVP Human Resources | Feb 12, 2016 | Option Exercise | $247.22 | 1,369 | 338,444 | 3,601 | Feb 17, 2016, 06:00 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 12, 2016 | Option Exercise | $247.22 | 26 | 6,428 | 2,643 | Feb 17, 2016, 05:59 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Feb 12, 2016 | Option Exercise | $247.22 | 1,827 | 451,671 | 8,712 | Feb 17, 2016, 05:57 PM |
Holtzman Steven H | EVP Corporate Development | Feb 12, 2016 | Option Exercise | $247.22 | 1,314 | 324,847 | 8,020 | Feb 17, 2016, 05:56 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 12, 2016 | Option Exercise | $247.22 | 1,328 | 328,308 | 31,504 | Feb 17, 2016, 05:55 PM |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 12, 2016 | Option Exercise | $247.22 | 352 | 87,021 | 2,452 | Feb 17, 2016, 05:54 PM |
Clancy Paul J | Executive VP and CFO | Feb 12, 2016 | Option Exercise | $247.22 | 1,699 | 420,027 | 26,564 | Feb 17, 2016, 05:53 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 09, 2016 | Option Exercise | $249.99 | 5,305 | 1,326,197 | 47,059 | Feb 10, 2016, 04:19 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Feb 08, 2016 | Option Exercise | $250.77 | 426 | 106,828 | 8,592 | Feb 10, 2016, 04:17 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Feb 09, 2016 | Sale | $246.54 | 852 | 210,052 | 7,740 | Feb 10, 2016, 04:17 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 08, 2016 | Option Exercise | $250.77 | 822 | 206,133 | 29,543 | Feb 09, 2016, 04:58 PM |
Clancy Paul J | Executive VP and CFO | Feb 08, 2016 | Option Exercise | $250.77 | 1,047 | 262,556 | 24,404 | Feb 09, 2016, 04:53 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2016 | Option Exercise | $250.77 | 1,324 | 332,019 | 28,342 | Feb 09, 2016, 04:51 PM |
Holtzman Steven H | EVP Corporate Development | Feb 08, 2016 | Option Exercise | $250.77 | 890 | 223,185 | 6,140 | Feb 09, 2016, 04:48 PM |
DiPietro Kenneth | EVP Human Resources | Feb 01, 2016 | Option Exercise | $273.45 | 812 | 222,041 | 1,654 | Feb 02, 2016, 04:05 PM |
DiPietro Kenneth | EVP Human Resources | Feb 01, 2016 | Option Exercise | $273.45 | 2,466 | 674,328 | 2,466 | Feb 02, 2016, 04:05 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Dec 03, 2015 | Option Exercise | $275.44 | 393 | 108,248 | 8,181 | Dec 07, 2015, 04:20 PM |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Dec 04, 2015 | Sale | $277.00 | 441 | 122,157 | 7,740 | Dec 07, 2015, 04:20 PM |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Dec 01, 2015 | Option Exercise | $290.04 | 171 | 49,597 | 7,923 | Dec 03, 2015, 04:19 PM |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Dec 02, 2015 | Sale | $289.14 | 48 | 13,879 | 7,875 | Dec 03, 2015, 04:19 PM |
DENNER ALEXANDER J | Director | Oct 23, 2015 | Buy | $276.77 | 100,000 | 27,676,999 | 310,000 | Oct 26, 2015, 07:03 PM |
DENNER ALEXANDER J | Director | Oct 22, 2015 | Buy | $277.80 | 210,000 | 58,337,997 | 210,000 | Oct 26, 2015, 07:03 PM |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Oct 05, 2015 | Sale | $291.43 | 269 | 78,395 | 8,094 | Oct 06, 2015, 04:40 PM |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Oct 01, 2015 | Option Exercise | $287.30 | 1,666 | 478,642 | 9,642 | Oct 05, 2015, 04:10 PM |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Oct 02, 2015 | Sale | $283.38 | 417 | 118,169 | 8,363 | Oct 05, 2015, 04:10 PM |
PAPADOPOULOS STELIOS | Director | Jul 27, 2015 | Buy | $304.98 | 5,000 | 1,524,895 | 5,000 | Jul 27, 2015, 05:03 PM |
PAPADOPOULOS STELIOS | Director | Jul 27, 2015 | Buy | $304.78 | 5,000 | 1,523,880 | 5,000 | Jul 27, 2015, 05:03 PM |
Posner Brian S | Director | Jun 22, 2015 | Sale | $415.00 | 470 | 195,050 | 5,275 | Jun 23, 2015, 04:14 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Jun 19, 2015 | Sale | $410.00 | 3,841 | 1,574,810 | 11,817 | Jun 22, 2015, 04:15 PM |
Posner Brian S | Director | Jun 15, 2015 | Sale | $386.64 | 400 | 154,656 | 5,745 | Jun 16, 2015, 06:54 PM |
Koppel Adam | SVP, Chief Strategy Officer | Jun 02, 2015 | Option Exercise | $387.62 | 852 | 330,252 | 1,662 | Jun 04, 2015, 05:49 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jun 01, 2015 | Sale | $398.87 | 1,362 | 543,261 | 41,090 | Jun 02, 2015, 04:10 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | May 01, 2015 | Option Exercise | $386.22 | 113 | 43,643 | 1,761 | May 05, 2015, 04:36 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | May 01, 2015 | Option Exercise | $386.22 | 347 | 134,018 | 1,874 | May 05, 2015, 04:36 PM |
SCANGOS GEORGE A | Chief Executive Officer | May 01, 2015 | Sale | $377.52 | 1,362 | 514,182 | 42,452 | May 05, 2015, 04:34 PM |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Apr 02, 2015 | Option Exercise | $412.44 | 460 | 189,722 | 1,674 | Apr 03, 2015, 04:24 PM |
SCANGOS GEORGE A | Chief Executive Officer | Apr 01, 2015 | Sale | $423.20 | 1,362 | 576,398 | 43,814 | Apr 02, 2015, 04:29 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Mar 27, 2015 | Sale | $430.12 | 430 | 184,952 | 8,574 | Mar 30, 2015, 04:13 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Mar 25, 2015 | Option Exercise | $65.85 | 5,066 | 333,571 | 37,577 | Mar 26, 2015, 04:31 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Mar 25, 2015 | Sale | $449.06 | 12,010 | 5,393,211 | 25,567 | Mar 26, 2015, 04:31 PM |
Rowinsky Eric K | Director | Mar 20, 2015 | Option Exercise | $59.82 | 11,667 | 697,920 | 22,977 | Mar 23, 2015, 04:33 PM |
Rowinsky Eric K | Director | Mar 20, 2015 | Sale | $475.00 | 11,667 | 5,541,825 | 11,310 | Mar 23, 2015, 04:33 PM |
Rowinsky Eric K | Director | Mar 19, 2015 | Option Exercise | $59.82 | 2,333 | 139,560 | 13,643 | Mar 20, 2015, 05:03 PM |
Rowinsky Eric K | Director | Mar 19, 2015 | Sale | $436.14 | 2,333 | 1,017,508 | 11,310 | Mar 20, 2015, 05:03 PM |
Rowinsky Eric K | Director | Mar 17, 2015 | Option Exercise | $59.82 | 4,667 | 279,180 | 15,977 | Mar 18, 2015, 05:03 PM |
Rowinsky Eric K | Director | Mar 17, 2015 | Sale | $425.45 | 4,667 | 1,985,589 | 11,310 | Mar 18, 2015, 05:03 PM |
DiPietro Kenneth | EVP Human Resources | Mar 16, 2015 | Sale | $415.46 | 803 | 333,614 | 0 | Mar 17, 2015, 08:10 PM |
SCANGOS GEORGE A | Chief Executive Officer | Mar 13, 2015 | Sale | $412.69 | 537 | 221,613 | 45,176 | Mar 16, 2015, 08:39 PM |
SHERWIN STEPHEN A | Director | Mar 10, 2015 | Option Exercise | $59.82 | 6,000 | 358,920 | 10,150 | Mar 11, 2015, 04:17 PM |
SHERWIN STEPHEN A | Director | Mar 10, 2015 | Sale | $409.67 | 6,000 | 2,458,020 | 4,150 | Mar 11, 2015, 04:17 PM |
Rowinsky Eric K | Director | Mar 09, 2015 | Option Exercise | $59.82 | 4,666 | 279,120 | 15,976 | Mar 11, 2015, 04:15 PM |
Rowinsky Eric K | Director | Mar 09, 2015 | Sale | $417.23 | 4,666 | 1,946,795 | 11,310 | Mar 11, 2015, 04:15 PM |
PANGIA ROBERT W | Director | Mar 10, 2015 | Option Exercise | $47.71 | 3,625 | 172,954 | 17,998 | Mar 11, 2015, 04:13 PM |
PANGIA ROBERT W | Director | Mar 10, 2015 | Sale | $413.40 | 3,625 | 1,498,578 | 17,798 | Mar 11, 2015, 04:13 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Mar 01, 2015 | Option Exercise | $409.59 | 2,826 | 1,157,501 | 12,178 | Mar 03, 2015, 04:44 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Mar 02, 2015 | Sale | $409.49 | 3,174 | 1,299,715 | 12,078 | Mar 03, 2015, 04:44 PM |
SCANGOS GEORGE A | Chief Executive Officer | Mar 02, 2015 | Sale | $410.67 | 825 | 338,803 | 45,713 | Mar 03, 2015, 04:39 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 12, 2015 | Option Exercise | $392.11 | 8 | 3,137 | 1,302 | Feb 23, 2015, 04:24 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 19, 2015 | Sale | $401.04 | 537 | 215,358 | 46,538 | Feb 20, 2015, 04:28 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 17, 2015 | Sale | $389.11 | 825 | 321,016 | 47,075 | Feb 18, 2015, 04:45 PM |
Holtzman Steven H | EVP Corporate Development | Feb 17, 2015 | Sale | $389.11 | 2,128 | 828,026 | 4,321 | Feb 18, 2015, 04:41 PM |
DiPietro Kenneth | EVP Human Resources | Feb 17, 2015 | Sale | $389.11 | 1,188 | 462,263 | 803 | Feb 18, 2015, 04:37 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 17, 2015 | Sale | $389.11 | 418 | 162,648 | 15,004 | Feb 18, 2015, 04:36 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 12, 2015 | Option Exercise | $392.11 | 12,125 | 4,754,334 | 47,900 | Feb 17, 2015, 09:32 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 12, 2015 | Option Exercise | $392.11 | 20 | 7,842 | 1,446 | Feb 17, 2015, 09:16 PM |
Holtzman Steven H | EVP Corporate Development | Feb 12, 2015 | Option Exercise | $392.11 | 1,712 | 671,292 | 6,449 | Feb 17, 2015, 08:54 PM |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 12, 2015 | Option Exercise | $392.11 | 394 | 154,491 | 1,159 | Feb 17, 2015, 08:50 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 12, 2015 | Option Exercise | $392.11 | 757 | 296,827 | 15,422 | Feb 17, 2015, 08:47 PM |
Clancy Paul J | Executive VP and CFO | Feb 12, 2015 | Option Exercise | $392.11 | 2,026 | 794,415 | 22,257 | Feb 17, 2015, 08:44 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2015 | Option Exercise | $392.11 | 1,761 | 690,506 | 32,511 | Feb 17, 2015, 08:40 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 12, 2015 | Option Exercise | $392.11 | 2,450 | 960,669 | 15,658 | Feb 17, 2015, 08:37 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 12, 2015 | Option Exercise | $392.11 | 1,776 | 696,387 | 27,867 | Feb 17, 2015, 08:34 PM |
DiPietro Kenneth | EVP Human Resources | Feb 12, 2015 | Option Exercise | $392.11 | 1,773 | 695,211 | 1,991 | Feb 17, 2015, 08:30 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 12, 2015 | Option Exercise | $392.11 | 1,697 | 665,411 | 8,132 | Feb 17, 2015, 08:26 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 10, 2015 | Sale | $398.11 | 1,143 | 455,039 | 15,417 | Feb 11, 2015, 04:26 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 10, 2015 | Option Exercise | $395.13 | 8,871 | 3,505,198 | 34,277 | Feb 11, 2015, 04:25 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 09, 2015 | Option Exercise | $396.88 | 4,940 | 1,960,587 | 24,315 | Feb 11, 2015, 04:25 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 08, 2015 | Option Exercise | $402.00 | 1,634 | 656,868 | 12,908 | Feb 10, 2015, 05:14 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 09, 2015 | Option Exercise | $396.88 | 1,842 | 731,053 | 25,874 | Feb 10, 2015, 05:12 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 08, 2015 | Option Exercise | $402.00 | 818 | 328,836 | 23,807 | Feb 10, 2015, 05:12 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 09, 2015 | Option Exercise | $396.88 | 681 | 270,275 | 15,717 | Feb 10, 2015, 05:11 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 08, 2015 | Option Exercise | $402.00 | 421 | 169,242 | 15,430 | Feb 10, 2015, 05:11 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 09, 2015 | Sale | $398.05 | 856 | 340,731 | 14,574 | Feb 10, 2015, 05:11 PM |
Holtzman Steven H | EVP Corporate Development | Feb 08, 2015 | Option Exercise | $402.00 | 1,275 | 512,550 | 4,527 | Feb 10, 2015, 05:10 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 09, 2015 | Option Exercise | $396.88 | 860 | 341,317 | 6,228 | Feb 10, 2015, 05:08 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 08, 2015 | Option Exercise | $402.00 | 883 | 354,966 | 5,264 | Feb 10, 2015, 05:08 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2015 | Option Exercise | $396.88 | 2,210 | 877,105 | 30,534 | Feb 10, 2015, 05:07 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2015 | Option Exercise | $402.00 | 1,537 | 617,874 | 28,053 | Feb 10, 2015, 05:07 PM |
Clancy Paul J | Executive VP and CFO | Feb 08, 2015 | Option Exercise | $402.00 | 1,143 | 459,486 | 17,503 | Feb 10, 2015, 05:06 PM |
Clancy Paul J | Executive VP and CFO | Feb 09, 2015 | Option Exercise | $396.88 | 2,210 | 877,105 | 19,984 | Feb 10, 2015, 05:06 PM |
DiPietro Kenneth | EVP Human Resources | Feb 02, 2015 | Sale | $389.03 | 1,656 | 644,234 | 0 | Feb 03, 2015, 06:35 PM |
DiPietro Kenneth | EVP Human Resources | Feb 01, 2015 | Option Exercise | $389.16 | 807 | 314,052 | 1,656 | Feb 02, 2015, 07:46 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 01, 2015 | Option Exercise | $389.16 | 2,059 | 801,280 | 11,074 | Feb 02, 2015, 07:43 PM |
Holtzman Steven H | EVP Corporate Development | Feb 01, 2015 | Option Exercise | $389.16 | 2,060 | 801,670 | 3,097 | Feb 02, 2015, 07:40 PM |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Dec 15, 2014 | Sale | $346.50 | 1,981 | 686,417 | 352 | Dec 16, 2014, 04:36 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Dec 03, 2014 | Option Exercise | $347.34 | 393 | 136,505 | 15,014 | Dec 05, 2014, 05:20 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Dec 04, 2014 | Sale | $345.88 | 440 | 152,187 | 14,574 | Dec 05, 2014, 05:20 PM |
Holtzman Steven H | EVP Corporate Development | Dec 02, 2014 | Sale | $335.65 | 1,749 | 587,052 | 0 | Dec 03, 2014, 04:32 PM |
Holtzman Steven H | EVP Corporate Development | Nov 11, 2014 | Sale | $330.00 | 1,750 | 577,500 | 1,749 | Nov 12, 2014, 04:24 PM |
SCANGOS GEORGE A | Chief Executive Officer | Nov 03, 2014 | Sale | $320.78 | 1,128 | 361,840 | 17,985 | Nov 04, 2014, 04:18 PM |
SCANGOS GEORGE A | Chief Executive Officer | Oct 01, 2014 | Sale | $330.97 | 1,127 | 373,003 | 19,113 | Oct 02, 2014, 04:44 PM |
Holtzman Steven H | EVP Corporate Development | Oct 01, 2014 | Sale | $330.97 | 1,750 | 579,198 | 3,499 | Oct 02, 2014, 04:42 PM |
SCANGOS GEORGE A | Chief Executive Officer | Sep 02, 2014 | Sale | $345.47 | 1,128 | 389,690 | 20,240 | Sep 04, 2014, 04:15 PM |
SCANGOS GEORGE A | Chief Executive Officer | Aug 01, 2014 | Sale | $332.93 | 1,128 | 375,545 | 21,368 | Aug 04, 2014, 04:43 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 16, 2014 | Sale | $312.37 | 12,316 | 3,847,149 | 22,496 | Jul 18, 2014, 05:59 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 15, 2014 | Option Exercise | $312.00 | 10,062 | 3,139,344 | 34,812 | Jul 17, 2014, 04:45 PM |
Posner Brian S | Director | Jun 20, 2014 | Sale | $315.00 | 605 | 190,575 | 6,000 | Jun 23, 2014, 04:37 PM |
Posner Brian S | Director | Jun 13, 2014 | Sale | $310.50 | 700 | 217,350 | 6,605 | Jun 16, 2014, 04:37 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jun 02, 2014 | Sale | $318.93 | 484 | 154,362 | 23,535 | Jun 03, 2014, 04:29 PM |
Holtzman Steven H | EVP Corporate Development | May 19, 2014 | Sale | $289.15 | 1,221 | 353,052 | 5,749 | May 20, 2014, 04:16 PM |
SCANGOS GEORGE A | Chief Executive Officer | May 01, 2014 | Sale | $285.56 | 2,123 | 606,241 | 25,656 | May 02, 2014, 04:22 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | May 01, 2014 | Option Exercise | $286.75 | 113 | 32,403 | 916 | May 02, 2014, 04:20 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | May 01, 2014 | Option Exercise | $286.75 | 347 | 99,502 | 1,029 | May 02, 2014, 04:20 PM |
Holtzman Steven H | EVP Corporate Development | Apr 17, 2014 | Sale | $291.00 | 1,221 | 355,311 | 6,970 | Apr 21, 2014, 05:07 PM |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Apr 02, 2014 | Option Exercise | $309.70 | 433 | 134,100 | 2,244 | Apr 03, 2014, 04:27 PM |
PANGIA ROBERT W | Director | Apr 01, 2014 | Option Exercise | $47.55 | 6,250 | 297,187 | 20,253 | Apr 02, 2014, 04:19 PM |
PANGIA ROBERT W | Director | Apr 01, 2014 | Sale | $308.42 | 6,250 | 1,927,625 | 14,003 | Apr 02, 2014, 04:19 PM |
SCANGOS GEORGE A | Chief Executive Officer | Apr 01, 2014 | Sale | $308.42 | 2,123 | 654,776 | 26,142 | Apr 02, 2014, 04:16 PM |
Posner Brian S | Director | Mar 31, 2014 | Sale | $296.76 | 3,000 | 890,275 | 8,935 | Apr 01, 2014, 04:15 PM |
DORSA CAROLINE | Director | Mar 20, 2014 | Option Exercise | $53.64 | 10,000 | 536,400 | 24,468 | Mar 21, 2014, 04:17 PM |
DORSA CAROLINE | Director | Mar 20, 2014 | Sale | $348.88 | 10,000 | 3,488,812 | 22,268 | Mar 21, 2014, 04:17 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Mar 19, 2014 | Sale | $352.29 | 3,505 | 1,234,776 | 9,886 | Mar 21, 2014, 04:15 PM |
Holtzman Steven H | EVP Corporate Development | Mar 17, 2014 | Sale | $334.83 | 1,221 | 408,827 | 8,191 | Mar 18, 2014, 05:08 PM |
SCANGOS GEORGE A | Chief Executive Officer | Mar 10, 2014 | Sale | $333.77 | 26,124 | 8,719,378 | 53,689 | Mar 12, 2014, 07:20 PM |
LEAMING NANCY | Director | Mar 10, 2014 | Sale | $327.65 | 2,000 | 655,300 | 7,660 | Mar 12, 2014, 07:16 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Mar 11, 2014 | Sale | $336.83 | 8,428 | 2,838,766 | 9,054 | Mar 12, 2014, 07:15 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Mar 04, 2014 | Sale | $342.58 | 3,171 | 1,086,321 | 15,407 | Mar 05, 2014, 03:12 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Mar 03, 2014 | Option Exercise | $340.68 | 2,829 | 963,784 | 18,578 | Mar 04, 2014, 03:22 PM |
SCANGOS GEORGE A | Chief Executive Officer | Mar 03, 2014 | Sale | $335.79 | 2,942 | 987,894 | 56,368 | Mar 04, 2014, 03:19 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 26, 2014 | Sale | $342.17 | 1,048 | 358,594 | 21,407 | Feb 27, 2014, 04:19 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 23, 2014 | Option Exercise | $347.11 | 940 | 326,283 | 22,455 | Feb 25, 2014, 02:21 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2014 | Option Exercise | $347.11 | 1,228 | 426,251 | 25,478 | Feb 25, 2014, 02:17 PM |
Clancy Paul J | Executive VP and CFO | Feb 23, 2014 | Option Exercise | $347.11 | 2,018 | 700,468 | 15,455 | Feb 25, 2014, 02:11 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 23, 2014 | Option Exercise | $347.11 | 1,803 | 625,839 | 22,127 | Feb 25, 2014, 02:07 PM |
Holtzman Steven H | EVP Corporate Development | Feb 18, 2014 | Sale | $327.90 | 1,222 | 400,694 | 9,412 | Feb 19, 2014, 04:23 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 12, 2014 | Option Exercise | $323.04 | 1,685 | 544,322 | 11,481 | Feb 14, 2014, 04:48 PM |
Clancy Paul J | Executive VP and CFO | Feb 12, 2014 | Option Exercise | $323.04 | 1,324 | 427,705 | 13,193 | Feb 14, 2014, 04:46 PM |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 12, 2014 | Option Exercise | $323.04 | 239 | 77,207 | 1,702 | Feb 14, 2014, 04:45 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 12, 2014 | Option Exercise | $323.04 | 1,010 | 326,270 | 20,109 | Feb 14, 2014, 04:43 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 12, 2014 | Option Exercise | $323.04 | 367 | 118,556 | 14,092 | Feb 14, 2014, 04:42 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 13, 2014 | Sale | $316.42 | 425 | 134,478 | 21,407 | Feb 14, 2014, 04:42 PM |
Holtzman Steven H | EVP Corporate Development | Feb 12, 2014 | Option Exercise | $323.04 | 1,010 | 326,270 | 10,634 | Feb 14, 2014, 04:39 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | Feb 12, 2014 | Option Exercise | $323.04 | 8 | 2,584 | 682 | Feb 14, 2014, 04:38 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 12, 2014 | Option Exercise | $323.04 | 4,333 | 1,399,732 | 57,817 | Feb 14, 2014, 04:37 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 13, 2014 | Sale | $316.81 | 486 | 153,970 | 57,331 | Feb 14, 2014, 04:37 PM |
DiPietro Kenneth | EVP Human Resources | Feb 12, 2014 | Option Exercise | $323.04 | 956 | 308,826 | 1,290 | Feb 14, 2014, 04:36 PM |
DiPietro Kenneth | EVP Human Resources | Feb 13, 2014 | Sale | $316.81 | 1,290 | 408,685 | 0 | Feb 14, 2014, 04:36 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2014 | Option Exercise | $323.04 | 1,059 | 342,099 | 24,108 | Feb 14, 2014, 04:34 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 11, 2014 | Sale | $314.31 | 2,085 | 655,336 | 14,522 | Feb 12, 2014, 05:03 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 11, 2014 | Sale | $314.31 | 2,456 | 771,945 | 54,454 | Feb 12, 2014, 05:00 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 10, 2014 | Option Exercise | $315.54 | 8,880 | 2,801,995 | 55,417 | Feb 11, 2014, 07:55 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 09, 2014 | Option Exercise | $315.54 | 4,850 | 1,530,369 | 45,464 | Feb 11, 2014, 07:55 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 09, 2014 | Option Exercise | $315.54 | 861 | 271,680 | 10,752 | Feb 11, 2014, 07:52 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 08, 2014 | Option Exercise | $315.54 | 1,243 | 392,216 | 9,789 | Feb 11, 2014, 07:52 PM |
Clancy Paul J | Executive VP and CFO | Feb 09, 2014 | Option Exercise | $315.54 | 2,212 | 697,974 | 11,710 | Feb 11, 2014, 07:49 PM |
Clancy Paul J | Executive VP and CFO | Feb 08, 2014 | Option Exercise | $315.54 | 1,047 | 330,370 | 9,231 | Feb 11, 2014, 07:49 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 08, 2014 | Option Exercise | $315.54 | 1,636 | 516,223 | 9,593 | Feb 11, 2014, 07:47 PM |
Holtzman Steven H | EVP Corporate Development | Feb 08, 2014 | Option Exercise | $315.54 | 1,276 | 402,629 | 9,502 | Feb 11, 2014, 07:45 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 09, 2014 | Option Exercise | $315.54 | 594 | 187,431 | 15,752 | Feb 11, 2014, 07:43 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Feb 08, 2014 | Option Exercise | $315.54 | 422 | 133,158 | 14,522 | Feb 11, 2014, 07:43 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 09, 2014 | Option Exercise | $315.54 | 1,746 | 550,933 | 18,977 | Feb 11, 2014, 06:07 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 08, 2014 | Option Exercise | $315.54 | 819 | 258,427 | 16,814 | Feb 11, 2014, 06:07 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2014 | Option Exercise | $315.54 | 1,441 | 454,693 | 20,442 | Feb 11, 2014, 06:07 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2014 | Option Exercise | $315.54 | 2,212 | 697,974 | 22,921 | Feb 11, 2014, 06:07 PM |
DiPietro Kenneth | EVP Human Resources | Feb 04, 2014 | Sale | $299.01 | 1,655 | 494,862 | 0 | Feb 05, 2014, 04:36 PM |
DiPietro Kenneth | EVP Human Resources | Feb 01, 2014 | Option Exercise | $312.64 | 808 | 252,613 | 1,655 | Feb 03, 2014, 05:29 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 01, 2014 | Option Exercise | $312.64 | 1,969 | 615,588 | 7,761 | Feb 03, 2014, 05:25 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 01, 2014 | Option Exercise | $312.64 | 1,701 | 531,801 | 8,396 | Feb 03, 2014, 05:20 PM |
Holtzman Steven H | EVP Corporate Development | Feb 01, 2014 | Option Exercise | $312.64 | 1,971 | 616,213 | 8,073 | Feb 03, 2014, 05:15 PM |
Rowinsky Eric K | Director | Jan 21, 2014 | Sale | $310.09 | 2,020 | 626,382 | 10,440 | Jan 22, 2014, 04:49 PM |
SCHENK LYNN | Director | Jan 15, 2014 | Sale | $297.48 | 1,000 | 297,480 | 3,100 | Jan 16, 2014, 10:27 AM |
YOUNG WILLIAM | Director | Jan 08, 2014 | Sale | $285.11 | 15,000 | 4,276,590 | 18,509 | Jan 09, 2014, 04:24 PM |
PANGIA ROBERT W | Director | Jan 06, 2014 | Option Exercise | $47.55 | 6,250 | 297,187 | 20,253 | Jan 07, 2014, 12:22 PM |
PANGIA ROBERT W | Director | Jan 06, 2014 | Sale | $278.03 | 6,250 | 1,737,687 | 14,003 | Jan 07, 2014, 12:22 PM |
SHERWIN STEPHEN A | Director | Jan 02, 2014 | Option Exercise | $59.82 | 5,500 | 329,010 | 9,460 | Jan 06, 2014, 11:19 AM |
SHERWIN STEPHEN A | Director | Jan 02, 2014 | Sale | $279.28 | 5,500 | 1,536,059 | 7,660 | Jan 06, 2014, 11:19 AM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Dec 03, 2013 | Option Exercise | $287.76 | 394 | 113,377 | 14,106 | Dec 05, 2013, 02:53 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Dec 04, 2013 | Sale | $285.90 | 439 | 125,510 | 13,667 | Dec 05, 2013, 02:53 PM |
SCHENK LYNN | Director | Dec 02, 2013 | Sale | $291.71 | 1,000 | 291,710 | 4,100 | Dec 02, 2013, 03:28 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Nov 22, 2013 | Option Exercise | $49.95 | 4,000 | 199,800 | 12,710 | Nov 25, 2013, 02:11 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Nov 22, 2013 | Sale | $288.00 | 4,000 | 1,152,000 | 8,710 | Nov 25, 2013, 02:11 PM |
SCHENK LYNN | Director | Nov 01, 2013 | Sale | $245.00 | 1,000 | 245,000 | 5,100 | Nov 05, 2013, 12:18 PM |
SCANGOS GEORGE A | Chief Executive Officer | Nov 01, 2013 | Sale | $245.57 | 2,239 | 549,831 | 40,156 | Nov 05, 2013, 12:13 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Oct 22, 2013 | Option Exercise | $60.56 | 15,030 | 910,217 | 29,530 | Oct 23, 2013, 05:03 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Oct 22, 2013 | Sale | $250.11 | 15,030 | 3,759,123 | 14,500 | Oct 23, 2013, 05:03 PM |
SCHENK LYNN | Director | Oct 01, 2013 | Sale | $242.85 | 1,000 | 242,850 | 6,100 | Oct 02, 2013, 05:09 PM |
SCANGOS GEORGE A | Chief Executive Officer | Oct 01, 2013 | Sale | $242.85 | 2,239 | 543,741 | 42,395 | Oct 02, 2013, 04:35 PM |
DiPietro Kenneth | EVP Human Resources | Sep 30, 2013 | Sale | $242.00 | 1,440 | 348,480 | 0 | Oct 02, 2013, 01:36 PM |
Clancy Paul J | Executive VP and CFO | Sep 18, 2013 | Option Exercise | $49.65 | 26,785 | 1,329,875 | 33,872 | Sep 19, 2013, 02:14 PM |
Clancy Paul J | Executive VP and CFO | Sep 18, 2013 | Sale | $245.00 | 26,785 | 6,562,325 | 7,087 | Sep 19, 2013, 02:14 PM |
Clancy Paul J | Executive VP and CFO | Sep 16, 2013 | Option Exercise | $56.11 | 99,030 | 5,556,895 | 51,027 | Sep 18, 2013, 04:34 PM |
Clancy Paul J | Executive VP and CFO | Sep 16, 2013 | Sale | $238.27 | 99,030 | 23,596,311 | 42,027 | Sep 18, 2013, 04:34 PM |
Holtzman Steven H | EVP Corporate Development | Sep 17, 2013 | Sale | $238.98 | 3,501 | 836,669 | 4,885 | Sep 18, 2013, 04:31 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Sep 16, 2013 | Option Exercise | $49.65 | 9,820 | 487,563 | 24,320 | Sep 18, 2013, 04:28 PM |
Sandrock Alfred | Grp SVP, Chief Medical Officer | Sep 16, 2013 | Sale | $240.10 | 9,820 | 2,357,821 | 14,500 | Sep 18, 2013, 04:28 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Sep 16, 2013 | Option Exercise | $49.59 | 4,000 | 198,360 | 12,710 | Sep 18, 2013, 04:26 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Sep 16, 2013 | Sale | $238.03 | 4,000 | 952,120 | 8,710 | Sep 18, 2013, 04:26 PM |
SCHENK LYNN | Director | Sep 11, 2013 | Sale | $235.25 | 900 | 211,726 | 3,325 | Sep 13, 2013, 02:33 PM |
SCANGOS GEORGE A | Chief Executive Officer | Sep 03, 2013 | Sale | $214.40 | 2,239 | 480,042 | 45,534 | Sep 04, 2013, 04:52 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Aug 26, 2013 | Sale | $211.35 | 4,368 | 923,168 | 4,571 | Aug 28, 2013, 12:30 PM |
SCANGOS GEORGE A | Chief Executive Officer | Aug 01, 2013 | Sale | $218.82 | 2,239 | 489,938 | 45,761 | Aug 02, 2013, 10:55 AM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 16, 2013 | Sale | $223.94 | 2,239 | 501,402 | 48,000 | Jul 18, 2013, 11:24 AM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 15, 2013 | Option Exercise | $224.33 | 20,011 | 4,489,068 | 60,177 | Jul 16, 2013, 06:19 PM |
DENNER ALEXANDER J | Director | Jun 14, 2013 | Sale | $212.00 | 2,900 | 614,800 | 6,325 | Jun 17, 2013, 03:46 PM |
PAPADOPOULOS STELIOS | Director | Jun 11, 2013 | Sale | $219.62 | 2,020 | 443,632 | 12,930 | Jun 13, 2013, 04:27 PM |
Posner Brian S | Director | Jun 11, 2013 | Sale | $219.62 | 2,020 | 443,632 | 8,130 | Jun 13, 2013, 04:23 PM |
SCHENK LYNN | Director | Jun 10, 2013 | Sale | $225.82 | 2,000 | 451,633 | 3,920 | Jun 11, 2013, 03:55 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jun 03, 2013 | Sale | $234.16 | 1,598 | 374,188 | 48,911 | Jun 04, 2013, 03:29 PM |
SHERWIN STEPHEN A | Director | Jun 03, 2013 | Option Exercise | $59.82 | 12,825 | 767,191 | 15,480 | Jun 04, 2013, 03:26 PM |
SHERWIN STEPHEN A | Director | Jun 03, 2013 | Sale | $233.26 | 12,825 | 2,991,605 | 12,047 | Jun 04, 2013, 03:26 PM |
Mulligan Richard | Director | May 29, 2013 | Option Exercise | $53.43 | 3,000 | 160,290 | 5,020 | May 31, 2013, 12:27 PM |
DENNER ALEXANDER J | Director | May 29, 2013 | Option Exercise | $53.43 | 3,000 | 160,290 | 7,920 | May 31, 2013, 12:26 PM |
Mulligan Richard | Director | May 28, 2013 | Option Exercise | $53.43 | 37,975 | 2,029,004 | 37,020 | May 29, 2013, 05:16 PM |
Mulligan Richard | Director | May 28, 2013 | Sale | $240.69 | 37,975 | 9,140,100 | 36,120 | May 29, 2013, 05:16 PM |
DENNER ALEXANDER J | Director | May 28, 2013 | Option Exercise | $53.43 | 37,975 | 2,029,004 | 39,920 | May 29, 2013, 05:15 PM |
DENNER ALEXANDER J | Director | May 28, 2013 | Sale | $240.57 | 37,975 | 9,135,697 | 37,620 | May 29, 2013, 05:15 PM |
PANGIA ROBERT W | Director | May 28, 2013 | Sale | $237.23 | 5,900 | 1,399,657 | 12,698 | May 29, 2013, 05:12 PM |
Pawlicki Raymond | SVP, Chief Information Officer | May 03, 2013 | Option Exercise | $218.85 | 866 | 189,524 | 8,710 | May 07, 2013, 01:36 PM |
Cox John | EVP Pharmaceutical Oper & Tech | May 03, 2013 | Option Exercise | $218.85 | 866 | 189,524 | 18,060 | May 07, 2013, 01:33 PM |
COVINO GREGORY F | VP, Chief Accounting Officer | May 01, 2013 | Option Exercise | $214.33 | 114 | 24,434 | 375 | May 03, 2013, 03:10 PM |
SCANGOS GEORGE A | Chief Executive Officer | May 01, 2013 | Sale | $215.39 | 1,598 | 344,193 | 50,509 | May 03, 2013, 03:07 PM |
Clancy Paul J | Executive VP and CFO | Apr 30, 2013 | Sale | $224.66 | 14,489 | 3,255,090 | 19,608 | May 01, 2013, 03:45 PM |
Clancy Paul J | Executive VP and CFO | Apr 29, 2013 | Sale | $219.71 | 9,123 | 2,004,414 | 21,576 | May 01, 2013, 03:45 PM |
SCANGOS GEORGE A | Chief Executive Officer | Apr 01, 2013 | Sale | $193.66 | 1,598 | 309,469 | 52,107 | Apr 03, 2013, 12:31 PM |
SCANGOS GEORGE A | Chief Executive Officer | Apr 01, 2013 | Sale | $193.66 | 1,598 | 309,469 | 52,107 | Apr 02, 2013, 01:23 PM |
Mulligan Richard | Director | Mar 22, 2013 | Sale | $176.88 | 2,900 | 512,952 | 2,020 | Mar 25, 2013, 02:20 PM |
SHERWIN STEPHEN A | Director | Mar 22, 2013 | Sale | $176.88 | 1,500 | 265,320 | 2,655 | Mar 25, 2013, 02:18 PM |
Posner Brian S | Director | Mar 18, 2013 | Sale | $174.81 | 4,500 | 786,645 | 10,150 | Mar 19, 2013, 03:15 PM |
Mulligan Richard | Director | Mar 13, 2013 | Sale | $175.38 | 7,980 | 1,399,530 | 9,920 | Mar 13, 2013, 02:56 PM |
PAPADOPOULOS STELIOS | Director | Mar 11, 2013 | Option Exercise | $58.44 | 46,675 | 2,727,463 | 49,950 | Mar 12, 2013, 02:22 PM |
PAPADOPOULOS STELIOS | Director | Mar 11, 2013 | Sale | $172.26 | 46,675 | 8,040,003 | 18,916 | Mar 12, 2013, 02:22 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Mar 01, 2013 | Option Exercise | $168.70 | 630 | 106,281 | 9,410 | Mar 04, 2013, 04:42 PM |
SCANGOS GEORGE A | Chief Executive Officer | Mar 01, 2013 | Sale | $165.30 | 1,598 | 264,149 | 53,705 | Mar 04, 2013, 04:40 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2013 | Option Exercise | $164.40 | 1,227 | 201,719 | 18,759 | Feb 26, 2013, 01:26 PM |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | Feb 23, 2013 | Option Exercise | $164.40 | 1,803 | 296,413 | 15,135 | Feb 26, 2013, 01:25 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Feb 23, 2013 | Option Exercise | $164.40 | 722 | 118,697 | 10,040 | Feb 26, 2013, 01:24 PM |
Clancy Paul J | Executive VP and CFO | Feb 23, 2013 | Option Exercise | $164.40 | 2,021 | 332,252 | 30,699 | Feb 26, 2013, 01:23 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 13, 2013 | Sale | $163.39 | 1,598 | 261,097 | 55,303 | Feb 14, 2013, 02:59 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 09, 2013 | Option Exercise | $164.44 | 861 | 141,583 | 5,511 | Feb 12, 2013, 05:26 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 08, 2013 | Option Exercise | $164.44 | 831 | 136,650 | 4,548 | Feb 12, 2013, 05:26 PM |
Clancy Paul J | Executive VP and CFO | Feb 09, 2013 | Option Exercise | $164.44 | 1,731 | 284,646 | 28,439 | Feb 12, 2013, 05:24 PM |
Clancy Paul J | Executive VP and CFO | Feb 08, 2013 | Option Exercise | $164.44 | 899 | 147,832 | 25,478 | Feb 12, 2013, 05:24 PM |
Holtzman Steven H | EVP Corporate Development | Feb 08, 2013 | Option Exercise | $164.44 | 940 | 154,574 | 8,386 | Feb 12, 2013, 05:22 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Feb 09, 2013 | Option Exercise | $164.44 | 893 | 146,845 | 9,233 | Feb 12, 2013, 05:20 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Feb 08, 2013 | Option Exercise | $164.44 | 523 | 86,002 | 8,236 | Feb 12, 2013, 05:20 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 08, 2013 | Option Exercise | $164.44 | 702 | 115,437 | 10,483 | Feb 12, 2013, 05:12 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 09, 2013 | Option Exercise | $164.44 | 1,275 | 209,661 | 13,117 | Feb 12, 2013, 05:12 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2013 | Option Exercise | $164.44 | 1,836 | 301,912 | 17,388 | Feb 12, 2013, 05:10 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 08, 2013 | Option Exercise | $164.44 | 1,133 | 186,311 | 14,532 | Feb 12, 2013, 05:10 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 08, 2013 | Option Exercise | $164.44 | 1,252 | 205,879 | 8,939 | Feb 12, 2013, 05:08 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 10, 2013 | Option Exercise | $164.44 | 8,890 | 1,461,872 | 56,901 | Feb 12, 2013, 05:05 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 09, 2013 | Option Exercise | $164.44 | 3,723 | 612,210 | 46,958 | Feb 12, 2013, 05:05 PM |
PANGIA ROBERT W | Director | Feb 06, 2013 | Option Exercise | $66.29 | 2,500 | 165,725 | 21,098 | Feb 07, 2013, 01:58 PM |
PANGIA ROBERT W | Director | Feb 06, 2013 | Sale | $165.55 | 2,500 | 413,875 | 18,598 | Feb 07, 2013, 01:58 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Feb 06, 2013 | Option Exercise | $49.65 | 10,000 | 496,500 | 17,653 | Feb 07, 2013, 01:55 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Feb 06, 2013 | Sale | $165.55 | 10,000 | 1,655,500 | 7,653 | Feb 07, 2013, 01:55 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 01, 2013 | Option Exercise | $157.30 | 1,679 | 264,107 | 7,185 | Feb 05, 2013, 06:23 PM |
Holtzman Steven H | EVP Corporate Development | Feb 01, 2013 | Option Exercise | $157.30 | 1,678 | 263,949 | 6,982 | Feb 05, 2013, 04:25 PM |
DiPietro Kenneth | EVP Human Resources | Feb 01, 2013 | Option Exercise | $157.30 | 711 | 111,840 | 1,440 | Feb 05, 2013, 04:23 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 01, 2013 | Option Exercise | $157.30 | 1,491 | 234,534 | 3,095 | Feb 05, 2013, 04:22 PM |
DENNER ALEXANDER J | Director | Dec 27, 2012 | Sale | $148.36 | 3,991 | 592,086 | 6,220 | Dec 28, 2012, 10:15 AM |
DENNER ALEXANDER J | Director | Dec 26, 2012 | Sale | $148.89 | 3,989 | 593,914 | 8,911 | Dec 28, 2012, 10:15 AM |
SCANGOS GEORGE A | Chief Executive Officer | Nov 01, 2012 | Sale | $139.42 | 2,472 | 344,640 | 52,898 | Nov 02, 2012, 03:49 PM |
SCANGOS GEORGE A | Chief Executive Officer | Oct 01, 2012 | Sale | $149.16 | 3,654 | 545,031 | 54,142 | Oct 02, 2012, 01:10 PM |
PANGIA ROBERT W | Director | Sep 17, 2012 | Option Exercise | $66.29 | 5,000 | 331,450 | 23,598 | Sep 18, 2012, 05:26 PM |
PANGIA ROBERT W | Director | Sep 17, 2012 | Sale | $155.00 | 5,000 | 775,000 | 18,598 | Sep 18, 2012, 05:26 PM |
PANGIA ROBERT W | Director | Sep 06, 2012 | Option Exercise | $66.29 | 5,000 | 331,450 | 23,598 | Sep 10, 2012, 02:20 PM |
PANGIA ROBERT W | Director | Sep 06, 2012 | Sale | $150.00 | 5,000 | 750,000 | 18,598 | Sep 10, 2012, 02:20 PM |
SHERWIN STEPHEN A | Director | Sep 04, 2012 | Sale | $145.90 | 2,000 | 291,800 | 4,155 | Sep 05, 2012, 03:20 PM |
SCANGOS GEORGE A | Chief Executive Officer | Sep 04, 2012 | Sale | $145.90 | 3,654 | 533,119 | 57,796 | Sep 05, 2012, 03:17 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Aug 02, 2012 | Sale | $142.99 | 1,165 | 166,583 | 9,020 | Aug 03, 2012, 11:12 AM |
SCANGOS GEORGE A | Chief Executive Officer | Aug 01, 2012 | Sale | $146.30 | 3,655 | 534,727 | 61,450 | Aug 02, 2012, 03:24 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Jul 27, 2012 | Option Exercise | $57.04 | 58,070 | 3,312,157 | 68,255 | Jul 30, 2012, 02:58 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Jul 27, 2012 | Sale | $150.00 | 58,070 | 8,710,500 | 10,185 | Jul 30, 2012, 02:58 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 17, 2012 | Sale | $146.04 | 2,472 | 361,011 | 66,333 | Jul 18, 2012, 03:35 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 16, 2012 | Option Exercise | $144.61 | 17,679 | 2,556,560 | 76,357 | Jul 17, 2012, 01:03 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 02, 2012 | Sale | $143.50 | 1,183 | 169,761 | 63,917 | Jul 03, 2012, 10:40 AM |
Pawlicki Raymond | SVP, Chief Information Officer | Jun 19, 2012 | Option Exercise | $49.59 | 10,000 | 495,900 | 17,653 | Jun 21, 2012, 11:41 AM |
Pawlicki Raymond | SVP, Chief Information Officer | Jun 19, 2012 | Sale | $143.00 | 10,000 | 1,430,000 | 7,653 | Jun 21, 2012, 11:41 AM |
ALEXANDER SUSAN H | EVP, General Counsel | Jun 15, 2012 | Option Exercise | $47.87 | 49,800 | 2,383,838 | 59,985 | Jun 18, 2012, 01:53 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Jun 15, 2012 | Sale | $140.00 | 49,800 | 6,972,000 | 10,185 | Jun 18, 2012, 01:53 PM |
PANGIA ROBERT W | Director | Jun 15, 2012 | Option Exercise | $36.94 | 5,000 | 184,700 | 23,598 | Jun 18, 2012, 01:50 PM |
PANGIA ROBERT W | Director | Jun 15, 2012 | Sale | $140.00 | 5,000 | 700,000 | 18,598 | Jun 18, 2012, 01:50 PM |
Posner Brian S | Director | Jun 07, 2012 | Option Exercise | $71.38 | 2,500 | 178,450 | 15,130 | Jun 11, 2012, 11:22 AM |
Posner Brian S | Director | Jun 07, 2012 | Sale | $135.00 | 2,500 | 337,500 | 12,630 | Jun 11, 2012, 11:22 AM |
PANGIA ROBERT W | Director | Jun 04, 2012 | Option Exercise | $36.94 | 5,000 | 184,700 | 21,578 | Jun 05, 2012, 03:45 PM |
PANGIA ROBERT W | Director | Jun 04, 2012 | Sale | $130.00 | 5,000 | 650,000 | 16,578 | Jun 05, 2012, 03:45 PM |
SHERWIN STEPHEN A | Director | Jun 04, 2012 | Sale | $126.45 | 2,500 | 316,125 | 4,135 | Jun 05, 2012, 03:43 PM |
Posner Brian S | Director | Jun 04, 2012 | Option Exercise | $71.38 | 2,400 | 171,312 | 15,030 | Jun 05, 2012, 03:41 PM |
Posner Brian S | Director | Jun 04, 2012 | Sale | $126.45 | 2,400 | 303,480 | 12,630 | Jun 05, 2012, 03:41 PM |
Pawlicki Raymond | SVP, Chief Information Officer | Jun 04, 2012 | Sale | $126.45 | 1,068 | 135,049 | 7,653 | Jun 05, 2012, 03:39 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jun 01, 2012 | Sale | $128.63 | 1,183 | 152,169 | 65,100 | Jun 04, 2012, 04:26 PM |
Cox John | EVP Pharmaceutical Oper & Tech | May 03, 2012 | Option Exercise | $134.26 | 765 | 102,709 | 12,178 | May 04, 2012, 02:03 PM |
Pawlicki Raymond | SVP, Chief Information Officer | May 03, 2012 | Option Exercise | $134.26 | 765 | 102,709 | 8,721 | May 04, 2012, 02:02 PM |
SCHENK LYNN | Director | May 02, 2012 | Option Exercise | $53.43 | 5,975 | 319,244 | 8,875 | May 03, 2012, 04:46 PM |
SCHENK LYNN | Director | May 02, 2012 | Sale | $135.00 | 5,975 | 806,625 | 2,900 | May 03, 2012, 04:46 PM |
SCHENK LYNN | Director | May 02, 2012 | Sale | $135.00 | 8,480 | 1,144,800 | 7,100 | May 03, 2012, 04:46 PM |
ALEXANDER SUSAN H | EVP, General Counsel | May 02, 2012 | Option Exercise | $44.73 | 20,000 | 894,600 | 30,185 | May 03, 2012, 04:34 PM |
ALEXANDER SUSAN H | EVP, General Counsel | May 02, 2012 | Sale | $135.00 | 20,000 | 2,700,000 | 10,185 | May 03, 2012, 04:34 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Apr 25, 2012 | Option Exercise | $44.73 | 16,764 | 749,854 | 26,949 | Apr 26, 2012, 03:44 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Apr 25, 2012 | Sale | $130.00 | 16,764 | 2,179,320 | 10,185 | Apr 26, 2012, 03:44 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Apr 04, 2012 | Option Exercise | $44.73 | 3,236 | 144,746 | 13,421 | Apr 06, 2012, 03:28 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Apr 04, 2012 | Sale | $130.00 | 3,236 | 420,680 | 10,185 | Apr 06, 2012, 03:28 PM |
PANGIA ROBERT W | Director | Mar 08, 2012 | Option Exercise | $35.21 | 7,500 | 264,050 | 21,578 | Mar 12, 2012, 03:02 PM |
PANGIA ROBERT W | Director | Mar 08, 2012 | Sale | $120.00 | 7,500 | 900,000 | 16,578 | Mar 12, 2012, 03:02 PM |
Gagnon Robert E. | Vice President, Finance | Feb 29, 2012 | Sale | $115.51 | 717 | 82,821 | 4,356 | Mar 01, 2012, 03:23 PM |
Gagnon Robert E. | Vice President, Finance | Feb 28, 2012 | Sale | $115.03 | 835 | 96,050 | 4,716 | Mar 01, 2012, 03:23 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 27, 2012 | Sale | $115.43 | 4,255 | 491,155 | 12,302 | Feb 28, 2012, 04:01 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 23, 2012 | Option Exercise | $116.70 | 1,413 | 164,897 | 19,186 | Feb 27, 2012, 04:20 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 24, 2012 | Option Exercise | $116.39 | 2,601 | 302,730 | 15,747 | Feb 27, 2012, 04:20 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 24, 2012 | Sale | $115.53 | 2,145 | 247,812 | 17,447 | Feb 27, 2012, 04:20 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 24, 2012 | Option Exercise | $116.39 | 1,578 | 183,663 | 13,506 | Feb 27, 2012, 04:19 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2012 | Option Exercise | $116.70 | 1,085 | 126,619 | 14,291 | Feb 27, 2012, 04:19 PM |
Gagnon Robert E. | Vice President, Finance | Feb 23, 2012 | Option Exercise | $116.70 | 388 | 45,280 | 5,885 | Feb 27, 2012, 04:18 PM |
Gagnon Robert E. | Vice President, Finance | Feb 24, 2012 | Option Exercise | $116.39 | 334 | 38,874 | 5,719 | Feb 27, 2012, 04:18 PM |
Gagnon Robert E. | Vice President, Finance | Feb 24, 2012 | Option Exercise | $49.65 | 1,054 | 52,331 | 6,939 | Feb 27, 2012, 04:18 PM |
Gagnon Robert E. | Vice President, Finance | Feb 24, 2012 | Sale | $115.53 | 1,054 | 121,769 | 5,885 | Feb 27, 2012, 04:18 PM |
Clancy Paul J | Executive VP and CFO | Feb 24, 2012 | Option Exercise | $116.39 | 2,786 | 324,263 | 25,012 | Feb 27, 2012, 04:17 PM |
Clancy Paul J | Executive VP and CFO | Feb 23, 2012 | Option Exercise | $116.70 | 1,786 | 208,426 | 26,398 | Feb 27, 2012, 04:17 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 15, 2011 | Option Exercise | $104.00 | 8,791 | 914,264 | 54,374 | Feb 22, 2012, 12:03 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 14, 2012 | Sale | $118.61 | 1,247 | 147,907 | 0 | Feb 16, 2012, 02:39 PM |
Gagnon Robert E. | Vice President, Finance | Feb 14, 2012 | Sale | $118.61 | 560 | 66,422 | 5,050 | Feb 16, 2012, 02:37 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 13, 2012 | Sale | $118.01 | 2,842 | 335,384 | 16,777 | Feb 14, 2012, 03:58 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 09, 2012 | Option Exercise | $117.78 | 579 | 68,195 | 1,247 | Feb 14, 2012, 03:57 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 09, 2012 | Option Exercise | $117.78 | 1,504 | 177,141 | 12,776 | Feb 13, 2012, 04:28 PM |
Gagnon Robert E. | Vice President, Finance | Feb 09, 2012 | Option Exercise | $117.78 | 301 | 35,452 | 5,610 | Feb 13, 2012, 04:27 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 09, 2012 | Option Exercise | $117.78 | 1,257 | 148,049 | 19,619 | Feb 13, 2012, 04:26 PM |
SCANGOS GEORGE A | Chief Executive Officer | Feb 10, 2012 | Option Exercise | $118.14 | 7,007 | 827,807 | 66,283 | Feb 13, 2012, 04:24 PM |
Clancy Paul J | Executive VP and CFO | Feb 09, 2012 | Option Exercise | $117.78 | 1,957 | 230,495 | 23,903 | Feb 13, 2012, 04:21 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 06, 2012 | Sale | $121.03 | 3,110 | 376,403 | 0 | Feb 08, 2012, 03:07 PM |
Clancy Paul J | Executive VP and CFO | Feb 01, 2012 | Option Exercise | $52.95 | 21,400 | 1,133,088 | 42,568 | Feb 03, 2012, 02:56 PM |
Clancy Paul J | Executive VP and CFO | Feb 01, 2012 | Sale | $120.00 | 21,400 | 2,568,000 | 29,568 | Feb 03, 2012, 02:56 PM |
WILLIAMS DOUGLAS E | EVP Research & Development | Feb 01, 2012 | Option Exercise | $121.26 | 1,656 | 200,807 | 3,906 | Feb 03, 2012, 02:55 PM |
Holtzman Steven H | EVP Corp Devel and Strategy | Feb 01, 2012 | Option Exercise | $121.26 | 1,658 | 201,049 | 3,501 | Feb 03, 2012, 02:54 PM |
Granata Francesco | EVP Global Commercial Operatio | Feb 01, 2012 | Option Exercise | $121.26 | 1,669 | 202,383 | 3,529 | Feb 03, 2012, 02:53 PM |
Kingsley Stuart A | EVP, Global Comm. Operations | Feb 01, 2012 | Option Exercise | $121.26 | 1,477 | 179,101 | 3,110 | Feb 03, 2012, 02:52 PM |
LEAMING NANCY | Director | Feb 01, 2012 | Option Exercise | $59.17 | 5,700 | 337,269 | 12,035 | Feb 03, 2012, 02:51 PM |
LEAMING NANCY | Director | Feb 01, 2012 | Sale | $120.00 | 5,700 | 684,000 | 6,335 | Feb 03, 2012, 02:51 PM |
LEAMING NANCY | Director | Jan 20, 2012 | Option Exercise | $55.97 | 3,000 | 167,910 | 9,335 | Jan 24, 2012, 03:55 PM |
LEAMING NANCY | Director | Jan 20, 2012 | Sale | $118.00 | 3,000 | 354,000 | 6,335 | Jan 24, 2012, 03:55 PM |
LEAMING NANCY | Director | Jan 06, 2012 | Option Exercise | $55.97 | 3,000 | 167,910 | 9,335 | Jan 09, 2012, 03:54 PM |
LEAMING NANCY | Director | Jan 06, 2012 | Sale | $116.00 | 3,000 | 348,000 | 6,335 | Jan 09, 2012, 03:54 PM |
Rowinsky Eric K | Director | Jan 06, 2012 | Option Exercise | $59.82 | 12,992 | 777,181 | 20,802 | Jan 09, 2012, 03:52 PM |
Rowinsky Eric K | Director | Jan 06, 2012 | Sale | $116.00 | 12,992 | 1,507,072 | 9,135 | Jan 09, 2012, 03:52 PM |
LEAMING NANCY | Director | Jan 03, 2012 | Option Exercise | $55.97 | 4,000 | 223,880 | 10,335 | Jan 04, 2012, 01:27 PM |
LEAMING NANCY | Director | Jan 03, 2012 | Sale | $114.00 | 4,000 | 456,000 | 6,335 | Jan 04, 2012, 01:27 PM |
Clancy Paul J | Executive VP and CFO | Jan 03, 2012 | Sale | $112.35 | 20,244 | 2,274,398 | 26,742 | Jan 04, 2012, 01:24 PM |
SHERWIN STEPHEN A | Director | Dec 19, 2011 | Sale | $110.88 | 2,500 | 277,200 | 6,635 | Dec 20, 2011, 03:10 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Dec 06, 2011 | Sale | $112.31 | 795 | 89,286 | 5,050 | Dec 08, 2011, 02:05 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Dec 01, 2011 | Option Exercise | $116.48 | 371 | 43,214 | 5,845 | Dec 02, 2011, 02:10 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Nov 09, 2011 | Sale | $112.04 | 796 | 89,184 | 6,216 | Nov 14, 2011, 11:26 AM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Nov 02, 2011 | Option Exercise | $113.43 | 371 | 42,083 | 7,012 | Nov 04, 2011, 11:50 AM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 01, 2011 | Option Exercise | $72.87 | 2,175 | 158,492 | 11,763 | Nov 03, 2011, 10:52 AM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 01, 2011 | Sale | $114.37 | 2,175 | 248,755 | 9,588 | Nov 03, 2011, 10:52 AM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Oct 05, 2011 | Sale | $97.66 | 252 | 24,610 | 7,383 | Oct 07, 2011, 01:48 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Oct 01, 2011 | Option Exercise | $93.15 | 118 | 10,992 | 7,635 | Oct 04, 2011, 06:28 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Oct 03, 2011 | Option Exercise | $49.59 | 778 | 38,581 | 8,413 | Oct 04, 2011, 06:28 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Oct 03, 2011 | Sale | $92.55 | 778 | 72,004 | 7,635 | Oct 04, 2011, 06:28 PM |
YOUNG WILLIAM | Director | Sep 27, 2011 | Option Exercise | $51.38 | 33,250 | 1,708,441 | 60,109 | Sep 29, 2011, 01:01 PM |
YOUNG WILLIAM | Director | Sep 27, 2011 | Sale | $96.14 | 33,250 | 3,196,655 | 26,859 | Sep 29, 2011, 01:01 PM |
LEAMING NANCY | Director | Sep 16, 2011 | Sale | $100.00 | 3,085 | 308,500 | 6,335 | Sep 19, 2011, 05:18 PM |
YOUNG WILLIAM | Director | Sep 01, 2011 | Option Exercise | $46.68 | 35,000 | 1,633,775 | 61,859 | Sep 02, 2011, 12:45 PM |
YOUNG WILLIAM | Director | Sep 01, 2011 | Sale | $95.00 | 35,000 | 3,325,000 | 26,859 | Sep 02, 2011, 12:45 PM |
Posner Brian S | Director | Aug 29, 2011 | Option Exercise | $71.38 | 15,000 | 1,070,700 | 27,630 | Aug 31, 2011, 11:44 AM |
Posner Brian S | Director | Aug 29, 2011 | Sale | $92.53 | 15,000 | 1,387,894 | 12,630 | Aug 31, 2011, 11:44 AM |
YOUNG WILLIAM | Director | Aug 29, 2011 | Option Exercise | $68.15 | 10,000 | 681,500 | 36,859 | Aug 31, 2011, 11:42 AM |
YOUNG WILLIAM | Director | Aug 29, 2011 | Sale | $92.58 | 10,000 | 925,784 | 26,859 | Aug 31, 2011, 11:42 AM |
ALEXANDER SUSAN H | EVP, General Counsel | Aug 01, 2011 | Option Exercise | $102.90 | 835 | 85,922 | 18,130 | Aug 03, 2011, 11:24 AM |
ALEXANDER SUSAN H | EVP, General Counsel | Aug 02, 2011 | Sale | $102.04 | 1,165 | 118,877 | 16,965 | Aug 03, 2011, 11:24 AM |
Clancy Paul J | Executive VP and CFO | Aug 01, 2011 | Option Exercise | $102.90 | 835 | 85,922 | 41,412 | Aug 03, 2011, 11:23 AM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 20, 2011 | Sale | $106.51 | 12,347 | 1,315,035 | 64,164 | Jul 21, 2011, 02:30 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 15, 2011 | Option Exercise | $104.00 | 8,911 | 926,744 | 66,804 | Jul 19, 2011, 04:29 PM |
SCANGOS GEORGE A | Chief Executive Officer | Jul 14, 2011 | Option Exercise | $104.00 | 8,791 | 914,264 | 54,374 | Jul 19, 2011, 04:29 PM |
Granata Francesco | EVP Global Commercial Operatio | Jul 01, 2011 | Sale | $107.52 | 2,901 | 311,918 | 0 | Jul 01, 2011, 01:51 PM |
LEAMING NANCY | Director | Jun 14, 2011 | Sale | $92.62 | 2,300 | 213,022 | 9,420 | Jun 14, 2011, 05:20 PM |
Posner Brian S | Director | May 25, 2011 | Option Exercise | $67.25 | 25,975 | 1,746,844 | 35,705 | May 27, 2011, 03:15 PM |
Posner Brian S | Director | May 25, 2011 | Sale | $94.09 | 25,975 | 2,444,027 | 22,900 | May 27, 2011, 03:15 PM |
LEAMING NANCY | Director | May 26, 2011 | Option Exercise | $55.51 | 33,175 | 1,841,628 | 41,995 | May 27, 2011, 03:13 PM |
LEAMING NANCY | Director | May 26, 2011 | Sale | $93.05 | 33,175 | 3,087,085 | 13,451 | May 27, 2011, 03:13 PM |
PANGIA ROBERT W | Director | May 26, 2011 | Option Exercise | $56.88 | 15,000 | 853,200 | 29,080 | May 27, 2011, 03:11 PM |
PANGIA ROBERT W | Director | May 26, 2011 | Sale | $93.11 | 15,000 | 1,396,647 | 16,280 | May 27, 2011, 03:11 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | May 06, 2011 | Sale | $96.13 | 967 | 92,960 | 7,753 | May 09, 2011, 04:38 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | May 03, 2011 | Option Exercise | $97.99 | 450 | 44,095 | 8,935 | May 04, 2011, 02:53 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | May 04, 2011 | Sale | $96.03 | 215 | 20,646 | 8,720 | May 04, 2011, 02:53 PM |
Cox John | EVP Pharmaceutical Oper & Tech | May 03, 2011 | Option Exercise | $97.99 | 765 | 74,962 | 9,588 | May 04, 2011, 02:51 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | May 01, 2011 | Option Exercise | $97.65 | 101 | 9,863 | 9,385 | May 03, 2011, 01:03 PM |
ALEXANDER SUSAN H | EVP, General Counsel | May 02, 2011 | Sale | $97.20 | 20,993 | 2,040,497 | 35,834 | May 03, 2011, 01:01 PM |
Clancy Paul J | Executive VP and CFO | Apr 28, 2011 | Option Exercise | $41.18 | 14,766 | 608,119 | 57,202 | Apr 29, 2011, 03:03 PM |
Clancy Paul J | Executive VP and CFO | Apr 28, 2011 | Sale | $98.91 | 19,716 | 1,950,088 | 48,497 | Apr 29, 2011, 03:03 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Apr 21, 2011 | Option Exercise | $72.87 | 4,350 | 316,985 | 14,703 | Apr 25, 2011, 02:02 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Apr 21, 2011 | Sale | $100.00 | 4,350 | 435,000 | 10,353 | Apr 25, 2011, 02:02 PM |
SCHENK LYNN | Director | Apr 20, 2011 | Option Exercise | $61.84 | 37,275 | 2,304,947 | 35,255 | Apr 21, 2011, 04:41 PM |
SCHENK LYNN | Director | Apr 20, 2011 | Sale | $85.22 | 37,275 | 3,176,461 | 7,980 | Apr 21, 2011, 04:41 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Apr 13, 2011 | Option Exercise | $56.73 | 36,234 | 2,055,646 | 46,587 | Apr 15, 2011, 11:50 AM |
Cox John | EVP Pharmaceutical Oper & Tech | Apr 13, 2011 | Sale | $80.00 | 36,234 | 2,898,720 | 10,353 | Apr 15, 2011, 11:50 AM |
Cox John | EVP Pharmaceutical Oper & Tech | Apr 11, 2011 | Option Exercise | $47.92 | 6,900 | 330,648 | 17,253 | Apr 13, 2011, 10:14 AM |
Cox John | EVP Pharmaceutical Oper & Tech | Apr 11, 2011 | Sale | $78.00 | 6,900 | 538,200 | 10,353 | Apr 13, 2011, 10:14 AM |
Clancy Paul J | Executive VP and CFO | Mar 05, 2011 | Option Exercise | $71.15 | 25,888 | 1,841,931 | 47,197 | Apr 08, 2011, 10:38 AM |
Clancy Paul J | Executive VP and CFO | Mar 05, 2011 | Option Exercise | $58.99 | 28,750 | 1,695,963 | 73,085 | Apr 08, 2011, 10:38 AM |
Cox John | EVP Pharmaceutical Oper & Tech | Mar 31, 2011 | Option Exercise | $43.50 | 2,840 | 123,540 | 12,658 | Apr 01, 2011, 03:20 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Mar 31, 2011 | Sale | $73.00 | 2,840 | 207,320 | 9,818 | Apr 01, 2011, 03:20 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Mar 01, 2011 | Option Exercise | $49.65 | 6,250 | 310,313 | 23,962 | Mar 03, 2011, 03:17 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Mar 02, 2011 | Sale | $70.10 | 7,511 | 526,552 | 13,633 | Mar 03, 2011, 03:17 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Mar 01, 2011 | Sale | $68.62 | 6,250 | 428,875 | 17,712 | Mar 03, 2011, 03:17 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Mar 02, 2011 | Sale | $70.10 | 4,041 | 283,259 | 12,401 | Mar 03, 2011, 03:10 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Mar 02, 2011 | Sale | $70.02 | 1,402 | 98,164 | 10,788 | Mar 03, 2011, 03:08 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 24, 2011 | Option Exercise | $67.26 | 1,980 | 133,175 | 40,953 | Feb 28, 2011, 03:41 PM |
Clancy Paul J | Executive VP and CFO | Feb 24, 2011 | Option Exercise | $67.26 | 2,164 | 145,551 | 45,401 | Feb 28, 2011, 03:39 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Feb 24, 2011 | Option Exercise | $67.26 | 335 | 22,532 | 11,056 | Feb 28, 2011, 03:36 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Feb 24, 2011 | Option Exercise | $67.26 | 2,156 | 145,013 | 18,707 | Feb 28, 2011, 03:34 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 24, 2011 | Option Exercise | $67.26 | 1,202 | 80,847 | 14,463 | Feb 28, 2011, 03:32 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 23, 2011 | Option Exercise | $66.76 | 680 | 45,397 | 15,190 | Feb 25, 2011, 03:56 PM |
Clancy Paul J | Executive VP and CFO | Feb 23, 2011 | Option Exercise | $66.76 | 1,119 | 74,704 | 46,711 | Feb 25, 2011, 03:55 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Feb 23, 2011 | Option Exercise | $66.76 | 320 | 21,363 | 11,284 | Feb 25, 2011, 03:54 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Feb 24, 2011 | Option Exercise | $49.65 | 1,054 | 52,331 | 12,277 | Feb 25, 2011, 03:54 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Feb 24, 2011 | Sale | $66.99 | 1,054 | 70,606 | 11,223 | Feb 25, 2011, 03:54 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Feb 23, 2011 | Option Exercise | $66.76 | 1,598 | 106,682 | 20,171 | Feb 25, 2011, 03:53 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Feb 25, 2011 | Option Exercise | $49.31 | 9,725 | 479,540 | 29,593 | Feb 25, 2011, 03:53 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Feb 25, 2011 | Sale | $68.20 | 9,725 | 663,245 | 19,868 | Feb 25, 2011, 03:53 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 23, 2011 | Option Exercise | $66.76 | 999 | 66,693 | 42,128 | Feb 25, 2011, 03:51 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Feb 17, 2011 | Sale | $67.10 | 732 | 49,115 | 10,537 | Feb 18, 2011, 03:09 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Feb 17, 2011 | Sale | $67.08 | 3,194 | 214,242 | 16,436 | Feb 18, 2011, 03:07 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 17, 2011 | Sale | $67.08 | 1,843 | 123,620 | 13,603 | Feb 18, 2011, 03:06 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Feb 12, 2011 | Option Exercise | $65.83 | 1,486 | 97,823 | 19,630 | Feb 15, 2011, 02:31 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Feb 12, 2011 | Option Exercise | $65.83 | 341 | 22,448 | 11,269 | Feb 15, 2011, 02:29 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Feb 12, 2011 | Option Exercise | $65.83 | 910 | 59,905 | 15,446 | Feb 15, 2011, 02:27 PM |
Clancy Paul J | Executive VP and CFO | Feb 12, 2011 | Option Exercise | $65.83 | 1,686 | 110,989 | 44,097 | Feb 15, 2011, 02:26 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Feb 12, 2011 | Option Exercise | $65.83 | 1,515 | 99,732 | 39,793 | Feb 15, 2011, 02:24 PM |
Granata Francesco | EVP Global Commercial Operatio | Feb 01, 2011 | Option Exercise | $65.49 | 1,385 | 90,704 | 3,162 | Feb 03, 2011, 05:14 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Jan 20, 2011 | Option Exercise | $49.65 | 6,250 | 310,313 | 27,366 | Jan 24, 2011, 02:59 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Jan 20, 2011 | Sale | $68.62 | 6,250 | 428,875 | 21,116 | Jan 24, 2011, 02:59 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Jan 04, 2011 | Option Exercise | $46.07 | 4,307 | 198,415 | 12,514 | Jan 05, 2011, 02:45 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Jan 04, 2011 | Sale | $66.57 | 5,103 | 339,690 | 10,814 | Jan 05, 2011, 02:45 PM |
YOUNG WILLIAM | Director | Dec 31, 2010 | Option Exercise | $67.05 | 13,256 | 888,815 | 21,059 | Jan 04, 2011, 03:58 PM |
YOUNG WILLIAM | Director | Dec 31, 2010 | Option Exercise | $59.25 | 15,000 | 888,750 | 34,315 | Jan 04, 2011, 03:58 PM |
SCHENK LYNN | Director | Dec 30, 2010 | Option Exercise | $59.25 | 15,000 | 888,750 | 22,980 | Jan 03, 2011, 09:57 AM |
SCHENK LYNN | Director | Dec 30, 2010 | Sale | $66.80 | 15,000 | 1,001,988 | 7,980 | Jan 03, 2011, 09:57 AM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Dec 17, 2010 | Option Exercise | $49.31 | 19,450 | 959,080 | 40,566 | Dec 21, 2010, 03:32 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Dec 17, 2010 | Sale | $68.20 | 19,450 | 1,326,490 | 21,116 | Dec 21, 2010, 03:32 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Dec 06, 2010 | Sale | $66.53 | 796 | 52,957 | 11,610 | Dec 07, 2010, 05:14 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Dec 03, 2010 | Option Exercise | $44.24 | 1,907 | 84,366 | 23,023 | Dec 07, 2010, 05:13 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Dec 07, 2010 | Option Exercise | $44.24 | 28,093 | 1,242,834 | 49,209 | Dec 07, 2010, 05:13 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Dec 03, 2010 | Sale | $67.20 | 1,907 | 128,150 | 21,116 | Dec 07, 2010, 05:13 PM |
SCHNEIER CRAIG ERIC | EVP, HR, Public Affairs & Comm | Dec 07, 2010 | Sale | $67.20 | 28,093 | 1,887,850 | 21,116 | Dec 07, 2010, 05:13 PM |
Gagnon Robert E. | Chief Acct Officer VP & Contr | Dec 01, 2010 | Option Exercise | $65.37 | 371 | 24,252 | 12,406 | Dec 03, 2010, 01:46 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 09, 2010 | Sale | $62.87 | 773 | 48,597 | 16,356 | Nov 10, 2010, 02:21 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 09, 2010 | Sale | $62.87 | 773 | 48,597 | 16,356 | Nov 10, 2010, 02:21 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 01, 2010 | Option Exercise | $62.55 | 360 | 22,518 | 17,894 | Nov 03, 2010, 01:50 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 01, 2010 | Option Exercise | $62.55 | 360 | 22,518 | 17,894 | Nov 03, 2010, 01:50 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 02, 2010 | Sale | $63.04 | 765 | 48,228 | 17,129 | Nov 03, 2010, 01:50 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Nov 02, 2010 | Sale | $63.04 | 765 | 48,228 | 17,129 | Nov 03, 2010, 01:50 PM |
PANGIA ROBERT W | Director | Oct 28, 2010 | Option Exercise | $59.25 | 15,000 | 888,750 | 29,080 | Oct 29, 2010, 02:27 PM |
PANGIA ROBERT W | Director | Oct 28, 2010 | Sale | $64.00 | 15,000 | 960,000 | 14,080 | Oct 29, 2010, 02:27 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Option Exercise | $33.97 | 6,900 | 234,393 | 25,154 | Oct 29, 2010, 02:25 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Option Exercise | $33.97 | 6,900 | 234,393 | 25,154 | Oct 29, 2010, 02:25 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Sale | $63.00 | 6,900 | 434,700 | 18,254 | Oct 29, 2010, 02:25 PM |
Cox John | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Sale | $63.00 | 6,900 | 434,700 | 18,254 | Oct 29, 2010, 02:25 PM |
MacLean Michael F | SVP, Chief Accounting Officer | Oct 01, 2010 | Option Exercise | $56.53 | 953 | 53,873 | 10,681 | Oct 04, 2010, 04:14 PM |
Clancy Paul J | Executive VP and CFO | Sep 04, 2010 | Option Exercise | $56.24 | 1,114 | 62,651 | 45,783 | Sep 07, 2010, 04:05 PM |
DORSA CAROLINE | Director | Aug 13, 2010 | Buy | $56.41 | 177 | 9,985 | 8,243 | Aug 17, 2010, 04:35 PM |
MacLean Michael F | SVP, Chief Accounting Officer | Aug 02, 2010 | Sale | $56.85 | 9,542 | 542,457 | 20,494 | Aug 03, 2010, 04:03 PM |
MacLean Michael F | SVP, Chief Accounting Officer | Aug 02, 2010 | Sale | $56.85 | 9,542 | 542,457 | 20,494 | Aug 03, 2010, 04:03 PM |
Clancy Paul J | Executive VP and CFO | Aug 01, 2010 | Option Exercise | $55.88 | 835 | 46,660 | 46,897 | Aug 03, 2010, 04:01 PM |
ALEXANDER SUSAN H | EVP, General Counsel | Aug 01, 2010 | Option Exercise | $55.88 | 835 | 46,660 | 41,308 | Aug 03, 2010, 04:00 PM |
DORSA CAROLINE | Director | Jul 30, 2010 | Buy | $54.57 | 183 | 9,986 | 8,066 | Aug 03, 2010, 03:58 PM |
Owner | Relationship | Date | Value($) |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 09/01/2023 | 722,428 |
Singhal Priya | Head of Development | 09/01/2023 | 215,606 |
Singhal Priya | Head of Development | 09/05/2023 | 116,124 |
Izzar Rachid | Head of Global Product Strat. | 06/30/2023 | 69,503 |
Kramer Robin | Chief Accounting Officer | 06/30/2023 | 34,752 |
Singhal Priya | Head of Development | 06/30/2023 | 43,582 |
Singhal Priya | Head of Development | 07/03/2023 | 22,912 |
Gregory Ginger | EVP, Human Resources | 04/28/2023 | 804,300 |
Singhal Priya | Head of Development | 04/04/2023 | 25,217 |
Murphy Nicole | Head of Pharm Ops and Tech | 03/31/2023 | 32,251 |
Singhal Priya | Head of Development | 03/28/2023 | 153,394 |
Singhal Priya | Head of Development | 03/02/2023 | 184,631 |
Singhal Priya | Head of Development | 02/17/2023 | 42,035 |
Murphy Nicole | Head of Pharm Ops and Tech | 02/17/2023 | 64,863 |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 02/17/2023 | 364,678 |
Kramer Robin | Chief Accounting Officer | 02/17/2023 | 66,254 |
Izzar Rachid | Head of Global Product Strat. | 02/17/2023 | 103,279 |
Gregory Ginger | EVP, Human Resources | 02/17/2023 | 241,355 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 02/17/2023 | 258,615 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 02/10/2023 | 1,203,033 |
Gregory Ginger | EVP, Human Resources | 02/10/2023 | 946,508 |
Izzar Rachid | Head of Global Product Strat. | 02/10/2023 | 379,061 |
Kramer Robin | Chief Accounting Officer | 02/10/2023 | 168,917 |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 02/10/2023 | 316,361 |
Murphy Nicole | Head of Pharm Ops and Tech | 02/10/2023 | 397,098 |
Singhal Priya | Head of Development | 02/10/2023 | 106,504 |
Gregory Ginger | EVP, Human Resources | 11/14/2022 | 1,683,617 |
Kramer Robin | Chief Accounting Officer | 12/08/2022 | 45,100 |
Izzar Rachid | Head of Alzheimer's Disease | 12/02/2022 | 226,865 |
Murphy Nicole | Head of Pharm Ops and Tech | 12/02/2022 | 11,657 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 10/27/2022 | 1,552,832 |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 09/01/2022 | 485,090 |
Murphy Nicole | Head of Pharm Ops and Tech | 08/01/2022 | 66,754 |
Kramer Robin | Chief Accounting Officer | 07/01/2022 | 15,587 |
Izzar Rachid | Head of Alzheimer's Disease | 07/01/2022 | 31,173 |
Murphy Nicole | Head of Pharm Ops and Tech | 04/01/2022 | 17,695 |
Vounatsos Michel | Chief Executive Officer | 02/18/2022 | 576,083 |
Murphy Nicole | Head of Pharm Ops and Tech | 02/18/2022 | 23,077 |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 02/18/2022 | 204,965 |
Gregory Ginger | EVP, Human Resources | 02/18/2022 | 129,231 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 02/18/2022 | 138,252 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 02/12/2022 | 441,197 |
Gregory Ginger | EVP, Human Resources | 02/12/2022 | 268,667 |
Guindo Chirfi | Head of Glob Prod Strat & Com | 02/12/2022 | 502,570 |
Kramer Robin | Chief Accounting Officer | 12/03/2021 | 22,392 |
Kramer Robin | Chief Accounting Officer | 12/03/2021 | 75,909 |
Izzar Rachid | Head of Alzheimer's Disease | 12/02/2021 | 37,706 |
Izzar Rachid | Head of Alzheimer's Disease | 12/02/2021 | 85,009 |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 09/01/2021 | 873,336 |
MCDONNELL MICHAEL R | EVP, Chief Financial Officer | 09/01/2021 | 2,031,131 |
Kramer Robin | Chief Accounting Officer | 07/01/2021 | 25,820 |
Kramer Robin | Chief Accounting Officer | 07/01/2021 | 87,579 |
Sandrock Alfred | Head of Research & Development | 06/07/2021 | 3,375,680 |
Guindo Chirfi | Head of Glob Prod Strat & Com | 06/07/2021 | 1,358,280 |
Posner Brian S | Director | 06/04/2021 | 98,701 |
Vounatsos Michel | Chief Executive Officer | 02/12/2021 | 4,023,928 |
Sandrock Alfred | EVP, Research & Development | 02/12/2021 | 975,885 |
Kramer Robin | SVP, Chief Accounting Officer | 02/12/2021 | 31,973 |
Gregory Ginger | EVP, Human Resources | 02/12/2021 | 606,661 |
Galdes Alphonse | EVP Pharmaceutical Oper & Tech | 02/12/2021 | 198,791 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 02/12/2021 | 1,083,205 |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | 02/12/2021 | 261,348 |
Mantas Jesus B | Director | 02/09/2021 | 239,766 |
Kramer Robin | VP, Chief Accounting Officer | 12/03/2020 | 5,370 |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | 12/01/2020 | 136,656 |
Vounatsos Michel | Chief Executive Officer | 11/30/2020 | 748,045 |
Sandrock Alfred | EVP, Research & Development | 11/04/2020 | 525,000 |
Gregory Ginger | EVP, Human Resources | 07/31/2020 | 61,256 |
SHERWIN STEPHEN A | Director | 03/11/2020 | 717,772 |
SHERWIN STEPHEN A | Director | 03/11/2020 | 718,574 |
Vounatsos Michel | Chief Executive Officer | 02/15/2020 | 715,950 |
Sandrock Alfred | EVP, Research & Development | 02/15/2020 | 179,154 |
Galdes Alphonse | EVP Pharmaceutical Oper & Tech | 02/15/2020 | 43,290 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 02/15/2020 | 229,437 |
Kramer Robin | VP, Chief Accounting Officer | 02/12/2020 | 15,261 |
Karp Daniel | EVP, Corporate Development | 02/12/2020 | 97,537 |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | 02/12/2020 | 167,207 |
Gregory Ginger | EVP, Human Resources | 02/12/2020 | 384,510 |
Galdes Alphonse | EVP Pharmaceutical Oper & Tech | 02/12/2020 | 116,448 |
CAPELLO JEFFREY D | EVP & Chief Financial Officer | 02/12/2020 | 203,701 |
ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | 02/12/2020 | 741,484 |
Vounatsos Michel | Chief Executive Officer | 02/12/2020 | 1,623,965 |
Sandrock Alfred | EVP, Research & Development | 02/12/2020 | 630,676 |
CAPELLO JEFFREY D | EVP & Chief Financial Officer | 01/02/2020 | 119,445 |
Kramer Robin | VP, Chief Accounting Officer | 12/03/2019 | 7,268 |
Guindo Chirfi | EVP Glob. Prod Strat and Comm | 12/01/2019 | 117,226 |
Posner Brian S | Director | 12/02/2019 | 308,429 |
Gregory Ginger | EVP, Human Resources | 08/01/2019 | 50,556 |
Karp Daniel | EVP, Corporate Development | 07/02/2019 | 13,709 |
Ehlers Michael D | EVP, Research and Development | 06/01/2019 | 210,518 |
Vounatsos Michel | Chief Executive Officer | 05/02/2019 | 151,682 |
DENNER ALEXANDER J | Director | 05/02/2019 | 8,787,120 |
DENNER ALEXANDER J | Director | 05/01/2019 | 6,883,800 |
DENNER ALEXANDER J | Director | 04/30/2019 | 11,540,904 |
Vounatsos Michel | Chief Executive Officer | 05/01/2019 | 1,007,169 |
PANGIA ROBERT W | Director | 03/18/2019 | 319,273 |
PANGIA ROBERT W | Director | 03/18/2019 | 2,008,755 |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | 03/01/2019 | 219,838 |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | 02/22/2019 | 1,336,781 |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | 02/22/2019 | 310,285 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/22/2019 | 240,419 |
Vounatsos Michel | Chief Executive Officer | 02/15/2019 | 778,916 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/15/2019 | 195,062 |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | 02/15/2019 | 214,035 |
Ehlers Michael D | EVP, Research and Development | 02/15/2019 | 249,320 |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | 02/15/2019 | 249,320 |
Vounatsos Michel | Chief Executive Officer | 02/12/2019 | 837,545 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/12/2019 | 804,325 |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | 02/12/2019 | 293,556 |
Gregory Ginger | EVP, Human Resources | 02/12/2019 | 176,006 |
Ehlers Michael D | EVP, Research and Development | 02/12/2019 | 404,718 |
ALEXANDER SUSAN H | EVP Chief Legal Officer & Sec. | 02/12/2019 | 326,138 |
DENNER ALEXANDER J | Director | 01/30/2019 | 9,745,860 |
DENNER ALEXANDER J | Director | 02/01/2019 | 2,299,164 |
DENNER ALEXANDER J | Director | 01/31/2019 | 8,527,391 |
CAPELLO JEFFREY D | EVP & Chief Financial Officer | 01/02/2019 | 126,142 |
Guindo Chirfi | EVP Glob. Mkt Acc & Cust Innov | 12/01/2018 | 136,491 |
Ehlers Michael D | EVP, Research and Development | 09/26/2018 | 350,000 |
Gregory Ginger | EVP, Human Resources | 08/01/2018 | 56,082 |
Ehlers Michael D | EVP, Research and Development | 06/01/2018 | 319,669 |
Vounatsos Michel | Chief Executive Officer | 05/02/2018 | 205,598 |
DENNER ALEXANDER J | Director | 04/25/2018 | 12,955,680 |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | 03/01/2018 | 181,269 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/27/2018 | 75,325 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/23/2018 | 60,898 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/23/2018 | 266,444 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/23/2018 | 8,198 |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | 02/23/2018 | 111,549 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/22/2018 | 207,057 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/22/2018 | 16,519 |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | 02/22/2018 | 207,057 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/20/2018 | 216,956 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/15/2018 | 386,712 |
Vounatsos Michel | Chief Executive Officer | 02/15/2018 | 561,936 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/15/2018 | 178,430 |
Ehlers Michael D | EVP, Research and Development | 02/15/2018 | 152,384 |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | 02/15/2018 | 152,684 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/15/2018 | 16,765 |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | 02/15/2018 | 132,326 |
Sandrock Alfred | EVP, Chief Medical Officer | 02/12/2018 | 416,685 |
PANGIA ROBERT W | Director | 01/09/2018 | 337,265 |
PANGIA ROBERT W | Director | 01/09/2018 | 1,922,519 |
Vounatsos Michel | Chief Executive Officer | 12/29/2017 | 250,029 |
COVINO GREGORY F | VP, Chief Accounting Officer | 12/01/2017 | 50,138 |
DENNER ALEXANDER J | Director | 11/29/2017 | 3,198,400 |
DENNER ALEXANDER J | Director | 11/28/2017 | 6,322,400 |
DENNER ALEXANDER J | Director | 08/31/2017 | 295,350 |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | 07/25/2017 | 1,442,510 |
ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | 07/19/2017 | 2,211,030 |
Posner Brian S | Director | 06/09/2017 | 277,840 |
Ehlers Michael D | EVP, Research and Development | 06/01/2017 | 188,528 |
Vounatsos Michel | Chief Executive Officer | 05/02/2017 | 153,036 |
Vounatsos Michel | Chief Executive Officer | 05/01/2017 | 380,433 |
DENNER ALEXANDER J | Director | 04/27/2017 | 20,569,476 |
Clancy Paul J | Executive VP and CFO | 04/25/2017 | 2,868,680 |
Clancy Paul J | Executive VP and CFO | 03/13/2017 | 2,883,721 |
McKenzie Paul | EVP Pharmaceutical Oper & Tech | 03/01/2017 | 46,042 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 03/01/2017 | 282,238 |
Clancy Paul J | Executive VP and CFO | 02/28/2017 | 853,135 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 02/28/2017 | 829,217 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/28/2017 | 670,996 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/28/2017 | 25,386 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 02/28/2017 | 211,542 |
DiPietro Kenneth | EVP Human Resources | 02/28/2017 | 684,399 |
PANGIA ROBERT W | Director | 01/09/2017 | 284,599 |
PANGIA ROBERT W | Director | 01/09/2017 | 1,609,876 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 12/01/2016 | 50,578 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 12/01/2016 | 14,233 |
COVINO GREGORY F | VP, Chief Accounting Officer | 12/01/2016 | 15,676 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 10/04/2016 | 81,728 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 10/01/2016 | 591,001 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 10/03/2016 | 118,940 |
DORSA CAROLINE | Director | 09/22/2016 | 1,478,855 |
DORSA CAROLINE | Director | 09/22/2016 | 8,656,980 |
SCANGOS GEORGE A | Chief Executive Officer | 07/21/2016 | 43,960 |
Koppel Adam | EVP, Strategy and Bus. Dev. | 06/06/2016 | 160,950 |
Koppel Adam | EVP, Strategy and Bus. Dev. | 06/02/2016 | 154,716 |
SCANGOS GEORGE A | Chief Executive Officer | 06/03/2016 | 244,180 |
SCANGOS GEORGE A | Chief Executive Officer | 06/01/2016 | 140,241 |
SCANGOS GEORGE A | Chief Executive Officer | 05/31/2016 | 976,720 |
SCANGOS GEORGE A | Chief Executive Officer | 05/25/2016 | 43,960 |
SCANGOS GEORGE A | Chief Executive Officer | 05/02/2016 | 133,798 |
COVINO GREGORY F | VP, Chief Accounting Officer | 05/01/2016 | 31,074 |
Koppel Adam | EVP, Strategy and Bus. Dev. | 04/06/2016 | 28,050 |
SCANGOS GEORGE A | Chief Executive Officer | 04/06/2016 | 43,960 |
Artavanis-Tsakonas Spyridon | EVP, Chief Scientific Officer | 04/02/2016 | 119,588 |
SCANGOS GEORGE A | Chief Executive Officer | 04/01/2016 | 126,050 |
SCANGOS GEORGE A | Chief Executive Officer | 03/01/2016 | 127,287 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 02/25/2016 | 47,928 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 02/25/2016 | 22,000 |
Clancy Paul J | Executive VP and CFO | 02/23/2016 | 70,704 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/23/2016 | 5,698 |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 02/23/2016 | 12,432 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/23/2016 | 77,697 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/23/2016 | 98,934 |
Koppel Adam | EVP, Strategy and Bus. Dev. | 02/23/2016 | 25,381 |
DiPietro Kenneth | EVP Human Resources | 02/23/2016 | 77,697 |
Holtzman Steven H | EVP Corporate Development | 02/23/2016 | 70,704 |
Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | 02/23/2016 | 41,956 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 02/23/2016 | 42,474 |
SCANGOS GEORGE A | Chief Executive Officer | 02/23/2016 | 361,291 |
SCANGOS GEORGE A | Chief Executive Officer | 02/17/2016 | 124,750 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 02/17/2016 | 184,948 |
SCANGOS GEORGE A | Chief Executive Officer | 02/12/2016 | 2,920,904 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/12/2016 | 383,685 |
DiPietro Kenneth | EVP Human Resources | 02/12/2016 | 338,444 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/12/2016 | 6,428 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 02/12/2016 | 451,671 |
Holtzman Steven H | EVP Corporate Development | 02/12/2016 | 324,847 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/12/2016 | 328,308 |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 02/12/2016 | 87,021 |
Clancy Paul J | Executive VP and CFO | 02/12/2016 | 420,027 |
SCANGOS GEORGE A | Chief Executive Officer | 02/09/2016 | 1,326,197 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 02/08/2016 | 106,828 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 02/09/2016 | 210,052 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/08/2016 | 206,133 |
Clancy Paul J | Executive VP and CFO | 02/08/2016 | 262,556 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/08/2016 | 332,019 |
Holtzman Steven H | EVP Corporate Development | 02/08/2016 | 223,185 |
DiPietro Kenneth | EVP Human Resources | 02/01/2016 | 222,041 |
DiPietro Kenneth | EVP Human Resources | 02/01/2016 | 674,328 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 12/03/2015 | 108,248 |
Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | 12/04/2015 | 122,157 |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | 12/01/2015 | 49,597 |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | 12/02/2015 | 13,879 |
DENNER ALEXANDER J | Director | 10/23/2015 | 27,676,999 |
DENNER ALEXANDER J | Director | 10/22/2015 | 58,337,997 |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | 10/05/2015 | 78,395 |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | 10/01/2015 | 478,642 |
Karaboutis Adriana | EVP, Tech. and Bus. Solutions | 10/02/2015 | 118,169 |
PAPADOPOULOS STELIOS | Director | 07/27/2015 | 1,524,895 |
PAPADOPOULOS STELIOS | Director | 07/27/2015 | 1,523,880 |
Posner Brian S | Director | 06/22/2015 | 195,050 |
WILLIAMS DOUGLAS E | EVP Research & Development | 06/19/2015 | 1,574,810 |
Posner Brian S | Director | 06/15/2015 | 154,656 |
Koppel Adam | SVP, Chief Strategy Officer | 06/02/2015 | 330,252 |
SCANGOS GEORGE A | Chief Executive Officer | 06/01/2015 | 543,261 |
COVINO GREGORY F | VP, Chief Accounting Officer | 05/01/2015 | 43,643 |
COVINO GREGORY F | VP, Chief Accounting Officer | 05/01/2015 | 134,018 |
SCANGOS GEORGE A | Chief Executive Officer | 05/01/2015 | 514,182 |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 04/02/2015 | 189,722 |
SCANGOS GEORGE A | Chief Executive Officer | 04/01/2015 | 576,398 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 03/27/2015 | 184,952 |
Cox John | EVP Pharmaceutical Oper & Tech | 03/25/2015 | 333,571 |
Cox John | EVP Pharmaceutical Oper & Tech | 03/25/2015 | 5,393,211 |
Rowinsky Eric K | Director | 03/20/2015 | 697,920 |
Rowinsky Eric K | Director | 03/20/2015 | 5,541,825 |
Rowinsky Eric K | Director | 03/19/2015 | 139,560 |
Rowinsky Eric K | Director | 03/19/2015 | 1,017,508 |
Rowinsky Eric K | Director | 03/17/2015 | 279,180 |
Rowinsky Eric K | Director | 03/17/2015 | 1,985,589 |
DiPietro Kenneth | EVP Human Resources | 03/16/2015 | 333,614 |
SCANGOS GEORGE A | Chief Executive Officer | 03/13/2015 | 221,613 |
SHERWIN STEPHEN A | Director | 03/10/2015 | 358,920 |
SHERWIN STEPHEN A | Director | 03/10/2015 | 2,458,020 |
Rowinsky Eric K | Director | 03/09/2015 | 279,120 |
Rowinsky Eric K | Director | 03/09/2015 | 1,946,795 |
PANGIA ROBERT W | Director | 03/10/2015 | 172,954 |
PANGIA ROBERT W | Director | 03/10/2015 | 1,498,578 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 03/01/2015 | 1,157,501 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 03/02/2015 | 1,299,715 |
SCANGOS GEORGE A | Chief Executive Officer | 03/02/2015 | 338,803 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/12/2015 | 3,137 |
SCANGOS GEORGE A | Chief Executive Officer | 02/19/2015 | 215,358 |
SCANGOS GEORGE A | Chief Executive Officer | 02/17/2015 | 321,016 |
Holtzman Steven H | EVP Corporate Development | 02/17/2015 | 828,026 |
DiPietro Kenneth | EVP Human Resources | 02/17/2015 | 462,263 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/17/2015 | 162,648 |
SCANGOS GEORGE A | Chief Executive Officer | 02/12/2015 | 4,754,334 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/12/2015 | 7,842 |
Holtzman Steven H | EVP Corporate Development | 02/12/2015 | 671,292 |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 02/12/2015 | 154,491 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/12/2015 | 296,827 |
Clancy Paul J | Executive VP and CFO | 02/12/2015 | 794,415 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/12/2015 | 690,506 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/12/2015 | 960,669 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/12/2015 | 696,387 |
DiPietro Kenneth | EVP Human Resources | 02/12/2015 | 695,211 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/12/2015 | 665,411 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/10/2015 | 455,039 |
SCANGOS GEORGE A | Chief Executive Officer | 02/10/2015 | 3,505,198 |
SCANGOS GEORGE A | Chief Executive Officer | 02/09/2015 | 1,960,587 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/08/2015 | 656,868 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/09/2015 | 731,053 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/08/2015 | 328,836 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/09/2015 | 270,275 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/08/2015 | 169,242 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/09/2015 | 340,731 |
Holtzman Steven H | EVP Corporate Development | 02/08/2015 | 512,550 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/09/2015 | 341,317 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/08/2015 | 354,966 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/09/2015 | 877,105 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/08/2015 | 617,874 |
Clancy Paul J | Executive VP and CFO | 02/08/2015 | 459,486 |
Clancy Paul J | Executive VP and CFO | 02/09/2015 | 877,105 |
DiPietro Kenneth | EVP Human Resources | 02/02/2015 | 644,234 |
DiPietro Kenneth | EVP Human Resources | 02/01/2015 | 314,052 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/01/2015 | 801,280 |
Holtzman Steven H | EVP Corporate Development | 02/01/2015 | 801,670 |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 12/15/2014 | 686,417 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 12/03/2014 | 136,505 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 12/04/2014 | 152,187 |
Holtzman Steven H | EVP Corporate Development | 12/02/2014 | 587,052 |
Holtzman Steven H | EVP Corporate Development | 11/11/2014 | 577,500 |
SCANGOS GEORGE A | Chief Executive Officer | 11/03/2014 | 361,840 |
SCANGOS GEORGE A | Chief Executive Officer | 10/01/2014 | 373,003 |
Holtzman Steven H | EVP Corporate Development | 10/01/2014 | 579,198 |
SCANGOS GEORGE A | Chief Executive Officer | 09/02/2014 | 389,690 |
SCANGOS GEORGE A | Chief Executive Officer | 08/01/2014 | 375,545 |
SCANGOS GEORGE A | Chief Executive Officer | 07/16/2014 | 3,847,149 |
SCANGOS GEORGE A | Chief Executive Officer | 07/15/2014 | 3,139,344 |
Posner Brian S | Director | 06/20/2014 | 190,575 |
Posner Brian S | Director | 06/13/2014 | 217,350 |
SCANGOS GEORGE A | Chief Executive Officer | 06/02/2014 | 154,362 |
Holtzman Steven H | EVP Corporate Development | 05/19/2014 | 353,052 |
SCANGOS GEORGE A | Chief Executive Officer | 05/01/2014 | 606,241 |
COVINO GREGORY F | VP, Chief Accounting Officer | 05/01/2014 | 32,403 |
COVINO GREGORY F | VP, Chief Accounting Officer | 05/01/2014 | 99,502 |
Holtzman Steven H | EVP Corporate Development | 04/17/2014 | 355,311 |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 04/02/2014 | 134,100 |
PANGIA ROBERT W | Director | 04/01/2014 | 297,187 |
PANGIA ROBERT W | Director | 04/01/2014 | 1,927,625 |
SCANGOS GEORGE A | Chief Executive Officer | 04/01/2014 | 654,776 |
Posner Brian S | Director | 03/31/2014 | 890,275 |
DORSA CAROLINE | Director | 03/20/2014 | 536,400 |
DORSA CAROLINE | Director | 03/20/2014 | 3,488,812 |
WILLIAMS DOUGLAS E | EVP Research & Development | 03/19/2014 | 1,234,776 |
Holtzman Steven H | EVP Corporate Development | 03/17/2014 | 408,827 |
SCANGOS GEORGE A | Chief Executive Officer | 03/10/2014 | 8,719,378 |
LEAMING NANCY | Director | 03/10/2014 | 655,300 |
Kingsley Stuart A | EVP, Global Comm. Operations | 03/11/2014 | 2,838,766 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 03/04/2014 | 1,086,321 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 03/03/2014 | 963,784 |
SCANGOS GEORGE A | Chief Executive Officer | 03/03/2014 | 987,894 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/26/2014 | 358,594 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/23/2014 | 326,283 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/23/2014 | 426,251 |
Clancy Paul J | Executive VP and CFO | 02/23/2014 | 700,468 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/23/2014 | 625,839 |
Holtzman Steven H | EVP Corporate Development | 02/18/2014 | 400,694 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/12/2014 | 544,322 |
Clancy Paul J | Executive VP and CFO | 02/12/2014 | 427,705 |
Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | 02/12/2014 | 77,207 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/12/2014 | 326,270 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/12/2014 | 118,556 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/13/2014 | 134,478 |
Holtzman Steven H | EVP Corporate Development | 02/12/2014 | 326,270 |
COVINO GREGORY F | VP, Chief Accounting Officer | 02/12/2014 | 2,584 |
SCANGOS GEORGE A | Chief Executive Officer | 02/12/2014 | 1,399,732 |
SCANGOS GEORGE A | Chief Executive Officer | 02/13/2014 | 153,970 |
DiPietro Kenneth | EVP Human Resources | 02/12/2014 | 308,826 |
DiPietro Kenneth | EVP Human Resources | 02/13/2014 | 408,685 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/12/2014 | 342,099 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/11/2014 | 655,336 |
SCANGOS GEORGE A | Chief Executive Officer | 02/11/2014 | 771,945 |
SCANGOS GEORGE A | Chief Executive Officer | 02/10/2014 | 2,801,995 |
SCANGOS GEORGE A | Chief Executive Officer | 02/09/2014 | 1,530,369 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/09/2014 | 271,680 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/08/2014 | 392,216 |
Clancy Paul J | Executive VP and CFO | 02/09/2014 | 697,974 |
Clancy Paul J | Executive VP and CFO | 02/08/2014 | 330,370 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/08/2014 | 516,223 |
Holtzman Steven H | EVP Corporate Development | 02/08/2014 | 402,629 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/09/2014 | 187,431 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 02/08/2014 | 133,158 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/09/2014 | 550,933 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/08/2014 | 258,427 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/08/2014 | 454,693 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/09/2014 | 697,974 |
DiPietro Kenneth | EVP Human Resources | 02/04/2014 | 494,862 |
DiPietro Kenneth | EVP Human Resources | 02/01/2014 | 252,613 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/01/2014 | 615,588 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/01/2014 | 531,801 |
Holtzman Steven H | EVP Corporate Development | 02/01/2014 | 616,213 |
Rowinsky Eric K | Director | 01/21/2014 | 626,382 |
SCHENK LYNN | Director | 01/15/2014 | 297,480 |
YOUNG WILLIAM | Director | 01/08/2014 | 4,276,590 |
PANGIA ROBERT W | Director | 01/06/2014 | 297,187 |
PANGIA ROBERT W | Director | 01/06/2014 | 1,737,687 |
SHERWIN STEPHEN A | Director | 01/02/2014 | 329,010 |
SHERWIN STEPHEN A | Director | 01/02/2014 | 1,536,059 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 12/03/2013 | 113,377 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 12/04/2013 | 125,510 |
SCHENK LYNN | Director | 12/02/2013 | 291,710 |
Pawlicki Raymond | SVP, Chief Information Officer | 11/22/2013 | 199,800 |
Pawlicki Raymond | SVP, Chief Information Officer | 11/22/2013 | 1,152,000 |
SCHENK LYNN | Director | 11/01/2013 | 245,000 |
SCANGOS GEORGE A | Chief Executive Officer | 11/01/2013 | 549,831 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 10/22/2013 | 910,217 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 10/22/2013 | 3,759,123 |
SCHENK LYNN | Director | 10/01/2013 | 242,850 |
SCANGOS GEORGE A | Chief Executive Officer | 10/01/2013 | 543,741 |
DiPietro Kenneth | EVP Human Resources | 09/30/2013 | 348,480 |
Clancy Paul J | Executive VP and CFO | 09/18/2013 | 1,329,875 |
Clancy Paul J | Executive VP and CFO | 09/18/2013 | 6,562,325 |
Clancy Paul J | Executive VP and CFO | 09/16/2013 | 5,556,895 |
Clancy Paul J | Executive VP and CFO | 09/16/2013 | 23,596,311 |
Holtzman Steven H | EVP Corporate Development | 09/17/2013 | 836,669 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 09/16/2013 | 487,563 |
Sandrock Alfred | Grp SVP, Chief Medical Officer | 09/16/2013 | 2,357,821 |
Pawlicki Raymond | SVP, Chief Information Officer | 09/16/2013 | 198,360 |
Pawlicki Raymond | SVP, Chief Information Officer | 09/16/2013 | 952,120 |
SCHENK LYNN | Director | 09/11/2013 | 211,726 |
SCANGOS GEORGE A | Chief Executive Officer | 09/03/2013 | 480,042 |
WILLIAMS DOUGLAS E | EVP Research & Development | 08/26/2013 | 923,168 |
SCANGOS GEORGE A | Chief Executive Officer | 08/01/2013 | 489,938 |
SCANGOS GEORGE A | Chief Executive Officer | 07/16/2013 | 501,402 |
SCANGOS GEORGE A | Chief Executive Officer | 07/15/2013 | 4,489,068 |
DENNER ALEXANDER J | Director | 06/14/2013 | 614,800 |
PAPADOPOULOS STELIOS | Director | 06/11/2013 | 443,632 |
Posner Brian S | Director | 06/11/2013 | 443,632 |
SCHENK LYNN | Director | 06/10/2013 | 451,633 |
SCANGOS GEORGE A | Chief Executive Officer | 06/03/2013 | 374,188 |
SHERWIN STEPHEN A | Director | 06/03/2013 | 767,191 |
SHERWIN STEPHEN A | Director | 06/03/2013 | 2,991,605 |
Mulligan Richard | Director | 05/29/2013 | 160,290 |
DENNER ALEXANDER J | Director | 05/29/2013 | 160,290 |
Mulligan Richard | Director | 05/28/2013 | 2,029,004 |
Mulligan Richard | Director | 05/28/2013 | 9,140,100 |
DENNER ALEXANDER J | Director | 05/28/2013 | 2,029,004 |
DENNER ALEXANDER J | Director | 05/28/2013 | 9,135,697 |
PANGIA ROBERT W | Director | 05/28/2013 | 1,399,657 |
Pawlicki Raymond | SVP, Chief Information Officer | 05/03/2013 | 189,524 |
Cox John | EVP Pharmaceutical Oper & Tech | 05/03/2013 | 189,524 |
COVINO GREGORY F | VP, Chief Accounting Officer | 05/01/2013 | 24,434 |
SCANGOS GEORGE A | Chief Executive Officer | 05/01/2013 | 344,193 |
Clancy Paul J | Executive VP and CFO | 04/30/2013 | 3,255,090 |
Clancy Paul J | Executive VP and CFO | 04/29/2013 | 2,004,414 |
SCANGOS GEORGE A | Chief Executive Officer | 04/01/2013 | 309,469 |
SCANGOS GEORGE A | Chief Executive Officer | 04/01/2013 | 309,469 |
Mulligan Richard | Director | 03/22/2013 | 512,952 |
SHERWIN STEPHEN A | Director | 03/22/2013 | 265,320 |
Posner Brian S | Director | 03/18/2013 | 786,645 |
Mulligan Richard | Director | 03/13/2013 | 1,399,530 |
PAPADOPOULOS STELIOS | Director | 03/11/2013 | 2,727,463 |
PAPADOPOULOS STELIOS | Director | 03/11/2013 | 8,040,003 |
Pawlicki Raymond | SVP, Chief Information Officer | 03/01/2013 | 106,281 |
SCANGOS GEORGE A | Chief Executive Officer | 03/01/2013 | 264,149 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/23/2013 | 201,719 |
ALEXANDER SUSAN H | EVP, Chief Legal Officer | 02/23/2013 | 296,413 |
Pawlicki Raymond | SVP, Chief Information Officer | 02/23/2013 | 118,697 |
Clancy Paul J | Executive VP and CFO | 02/23/2013 | 332,252 |
SCANGOS GEORGE A | Chief Executive Officer | 02/13/2013 | 261,097 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/09/2013 | 141,583 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/08/2013 | 136,650 |
Clancy Paul J | Executive VP and CFO | 02/09/2013 | 284,646 |
Clancy Paul J | Executive VP and CFO | 02/08/2013 | 147,832 |
Holtzman Steven H | EVP Corporate Development | 02/08/2013 | 154,574 |
Pawlicki Raymond | SVP, Chief Information Officer | 02/09/2013 | 146,845 |
Pawlicki Raymond | SVP, Chief Information Officer | 02/08/2013 | 86,002 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/08/2013 | 115,437 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/09/2013 | 209,661 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/09/2013 | 301,912 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/08/2013 | 186,311 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/08/2013 | 205,879 |
SCANGOS GEORGE A | Chief Executive Officer | 02/10/2013 | 1,461,872 |
SCANGOS GEORGE A | Chief Executive Officer | 02/09/2013 | 612,210 |
PANGIA ROBERT W | Director | 02/06/2013 | 165,725 |
PANGIA ROBERT W | Director | 02/06/2013 | 413,875 |
Pawlicki Raymond | SVP, Chief Information Officer | 02/06/2013 | 496,500 |
Pawlicki Raymond | SVP, Chief Information Officer | 02/06/2013 | 1,655,500 |
WILLIAMS DOUGLAS E | EVP Research & Development | 02/01/2013 | 264,107 |
Holtzman Steven H | EVP Corporate Development | 02/01/2013 | 263,949 |
DiPietro Kenneth | EVP Human Resources | 02/01/2013 | 111,840 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/01/2013 | 234,534 |
DENNER ALEXANDER J | Director | 12/27/2012 | 592,086 |
DENNER ALEXANDER J | Director | 12/26/2012 | 593,914 |
SCANGOS GEORGE A | Chief Executive Officer | 11/01/2012 | 344,640 |
SCANGOS GEORGE A | Chief Executive Officer | 10/01/2012 | 545,031 |
PANGIA ROBERT W | Director | 09/17/2012 | 331,450 |
PANGIA ROBERT W | Director | 09/17/2012 | 775,000 |
PANGIA ROBERT W | Director | 09/06/2012 | 331,450 |
PANGIA ROBERT W | Director | 09/06/2012 | 750,000 |
SHERWIN STEPHEN A | Director | 09/04/2012 | 291,800 |
SCANGOS GEORGE A | Chief Executive Officer | 09/04/2012 | 533,119 |
ALEXANDER SUSAN H | EVP, General Counsel | 08/02/2012 | 166,583 |
SCANGOS GEORGE A | Chief Executive Officer | 08/01/2012 | 534,727 |
ALEXANDER SUSAN H | EVP, General Counsel | 07/27/2012 | 3,312,157 |
ALEXANDER SUSAN H | EVP, General Counsel | 07/27/2012 | 8,710,500 |
SCANGOS GEORGE A | Chief Executive Officer | 07/17/2012 | 361,011 |
SCANGOS GEORGE A | Chief Executive Officer | 07/16/2012 | 2,556,560 |
SCANGOS GEORGE A | Chief Executive Officer | 07/02/2012 | 169,761 |
Pawlicki Raymond | SVP, Chief Information Officer | 06/19/2012 | 495,900 |
Pawlicki Raymond | SVP, Chief Information Officer | 06/19/2012 | 1,430,000 |
ALEXANDER SUSAN H | EVP, General Counsel | 06/15/2012 | 2,383,838 |
ALEXANDER SUSAN H | EVP, General Counsel | 06/15/2012 | 6,972,000 |
PANGIA ROBERT W | Director | 06/15/2012 | 184,700 |
PANGIA ROBERT W | Director | 06/15/2012 | 700,000 |
Posner Brian S | Director | 06/07/2012 | 178,450 |
Posner Brian S | Director | 06/07/2012 | 337,500 |
PANGIA ROBERT W | Director | 06/04/2012 | 184,700 |
PANGIA ROBERT W | Director | 06/04/2012 | 650,000 |
SHERWIN STEPHEN A | Director | 06/04/2012 | 316,125 |
Posner Brian S | Director | 06/04/2012 | 171,312 |
Posner Brian S | Director | 06/04/2012 | 303,480 |
Pawlicki Raymond | SVP, Chief Information Officer | 06/04/2012 | 135,049 |
SCANGOS GEORGE A | Chief Executive Officer | 06/01/2012 | 152,169 |
Cox John | EVP Pharmaceutical Oper & Tech | 05/03/2012 | 102,709 |
Pawlicki Raymond | SVP, Chief Information Officer | 05/03/2012 | 102,709 |
SCHENK LYNN | Director | 05/02/2012 | 319,244 |
SCHENK LYNN | Director | 05/02/2012 | 806,625 |
SCHENK LYNN | Director | 05/02/2012 | 1,144,800 |
ALEXANDER SUSAN H | EVP, General Counsel | 05/02/2012 | 894,600 |
ALEXANDER SUSAN H | EVP, General Counsel | 05/02/2012 | 2,700,000 |
ALEXANDER SUSAN H | EVP, General Counsel | 04/25/2012 | 749,854 |
ALEXANDER SUSAN H | EVP, General Counsel | 04/25/2012 | 2,179,320 |
ALEXANDER SUSAN H | EVP, General Counsel | 04/04/2012 | 144,746 |
ALEXANDER SUSAN H | EVP, General Counsel | 04/04/2012 | 420,680 |
PANGIA ROBERT W | Director | 03/08/2012 | 264,050 |
PANGIA ROBERT W | Director | 03/08/2012 | 900,000 |
Gagnon Robert E. | Vice President, Finance | 02/29/2012 | 82,821 |
Gagnon Robert E. | Vice President, Finance | 02/28/2012 | 96,050 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/27/2012 | 491,155 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/23/2012 | 164,897 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/24/2012 | 302,730 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/24/2012 | 247,812 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/24/2012 | 183,663 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/23/2012 | 126,619 |
Gagnon Robert E. | Vice President, Finance | 02/23/2012 | 45,280 |
Gagnon Robert E. | Vice President, Finance | 02/24/2012 | 38,874 |
Gagnon Robert E. | Vice President, Finance | 02/24/2012 | 52,331 |
Gagnon Robert E. | Vice President, Finance | 02/24/2012 | 121,769 |
Clancy Paul J | Executive VP and CFO | 02/24/2012 | 324,263 |
Clancy Paul J | Executive VP and CFO | 02/23/2012 | 208,426 |
SCANGOS GEORGE A | Chief Executive Officer | 07/15/2011 | 914,264 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/14/2012 | 147,907 |
Gagnon Robert E. | Vice President, Finance | 02/14/2012 | 66,422 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/13/2012 | 335,384 |
Kingsley Stuart A | EVP, Global Comm. Operations | 02/09/2012 | 68,195 |
Cox John | EVP Pharmaceutical Oper & Tech | 02/09/2012 | 177,141 |
Gagnon Robert E. | Vice President, Finance | 02/09/2012 | 35,452 |
ALEXANDER SUSAN H | EVP, General Counsel | 02/09/2012 | 148,049 |